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Preface

This doctoral dissertation is based on two technical articles and one review paper in peerreviewed journals finished in 2016. They are all related to the design of bio-degradable Znbased metallic stents. The full references for the three articles presented herein are listed
below.
In Chapter 3 “Results and Discussions: Structural characteristics and in vitro
biodegradation of a novel Zn-Li alloy prepared by induction melting and hot rolling”, I
performed majority of materials preparation, all materials characterization and all writing
under supervision of Professor Jaroslaw W. Drelich and Professor Jeremy Goldman, while
Cameron T. McNamara, Nicholas Verhun and Jacob Braykovich contributed to the wire
EDM cutting and hot rolling. In Chapter 4 “Results and Discussions: Zn-Li Alloy after
Extrusion and Drawing: Structural, Mechanical Characterization, and Biodegradation in
Abdominal Aorta of Rat”, I performed majority of materials preparation, characterization
and writing under supervision of Professor Jaroslaw W. Drelich and Professor Jeremy
Goldman, while Dr. Jan-M. Seitz and his team in Germany contributed to the wire
extrusion; Roger Guillory and Elisha Earley contributed to the histological analysis, and
Professor Jeremy Goldman contributed to the animal surgeries. Professors, staff, graduate
and undergraduate students who assisted during the finishing of this dissertation are listed
in the Acknowledgements section.
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Abstract

Zinc has begun to be studied as a bio-degradable material in recent years due to its excellent
corrosion rate and optimal biocompatibility. Unfortunately, pure Zn’s intrinsic ultimate
tensile strength (UTS; below 120 MPa) is lower than the benchmark (about 300 MPa) for
cardiovascular stent materials, raising concerns about sufficient strength to support the
blood vessel. Thus, modifying pure Zn to improve its mechanical properties is an important
research topic.
In this dissertation project, a new Zn-Li alloy has been developed to retain the outstanding
corrosion behavior from Zn while improving the mechanical characteristics and uniform
biodegradation once it is implanted into the artery of Sprague-Dawley rats.
The completed work includes:
•

Manufactured Zn-Li alloy ingots and sheets via induction vacuum casting, melt
spinning, hot rolling deformation, and wire electro discharge machining (wire EDM)
technique; processed alloy samples using cross sectioning, mounting, etching and
polishing technique;

•

Characterized alloy ingots, sheets and wires using hardness and tensile test, XRD,
BEI imaging, SEM, ESEM, FTIR, ICP-OES and electrochemical test; then selected
the optimum composition for in vitro and in vivo experiments;

•

Mimicked the degradation behavior of the Zn-Li alloy in vitro using simulated body
fluid (SBF) and explored the relations between corrosion rate, corrosion products
and surface morphology with changing compositions;
16

•

Explanted the Zn-Li alloy wire in abdominal aorta of rat over 12 months and studied
its degradation mechanism, rate of bioabsorption, cytotoxicity and corrosion
product migration from histological analysis.
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Introduction

Bio-degradable stents are envisaged to support the arterial wall during remodeling and to
degrade thereafter. Therefore, it may eliminate the potential chronic inflammation [1] and
thrombosis risks [2] of permanent stents and alleviate the repeating procedures for stenting
at the same site in the event of restenosis [3]. Over the past several years, Mg-based and
Fe-based materials have been widely investigated for coronary stent applications with very
limited success [4-6]. These previous reports demonstrated that neither iron nor magnesium
is ideal as a stent material due to either incomplete degradation of iron corrosion products
[7] or premature degradation of magnesium [8]. Consequently, new bio-degradable
materials are needed.
Zinc is one of the most abundant nutritionally essential elements in the human body [9].
Zinc has begun to be studied as a bio-degradable material in recent years [10]. It is
metallically bio-degradable and exhibits both an excellent corrosion rate and optimal
biocompatibility. Unfortunately, pure Zn’s intrinsic ultimate tensile strength (UTS; below
120 MPa) is lower than the benchmark (about 300 MPa) for cardiovascular stent materials,
raising concerns about sufficient strength to support the blood vessel. Thus, modifying pure
Zn to improve its mechanical properties is an important research topic.
Li is one of the few elements with significant solubility in zinc, and Zn-Li is therefore
among a few potentially age-hardenable systems. The idea of adding lithium into zinc to
improve the strength largely comes from the positive effects observed for magnesium
alloys such as LAE442, which has 4 wt.% lithium, 4 wt.% aluminium and 2 wt.% rare18

earth elements. LAE442 has been shown to be non-allergenic [11], bio-degradable, and to
degrade at a lower rate than the pure material without the formation of radiographic gas
[12, 13] and with a more uniform degradation behavior [13]. It is now widely considered
as the most promising implant for orthopedic use [14]. The toxic potential of a zinc-lithium
stent should therefore be negligible in terms of the released elements and their quantities.
Indeed, based upon the projected rate of stent corrosion, the quantity of released elements
will never exceed the level that can be safely assimilated by the body and its organs. With
regard to local toxic effects, rapid transport of ions in vascular tissue [15] should prevent
elemental enrichment, cytotoxicity, or necrosis in the implant’s vicinity.
However, a review of the available literature suggests most of the previous studies in this
binary Li-Zn system focused on its thermodynamic properties, preliminary chargedischarge, polarization characteristics [16], and the reactivity of lithium-ion batteries [17].
Currently, no research has been conducted on Zn-Li alloys as a bio-degradable implant
material.
This dissertation research creatively addresses this challenge by alloying Li with Zn to
improve its mechanical properties through manipulation of metal micro-/nano-structure.
Chapter 1 provides an extensive review of the current status on the stenting technique and
conventional metallic and polymeric Absorbable Metal Stent (AMS). Chapter 2 validates
the proposed Zn-Li alloy in stent application and provides the detailed research diagram
and hypotheses. Chapter 3 shows the structural characteristics of Zn-xLi alloy (with x=2,
4, 6 at.%) and the in vitro biodegradation results, suggesting that addition of Li for further
in vivo test should be less than 4 at.%. Chapter 4 lists the characteristics and preliminary
19

in vivo degradation results of Zn-Li wire obtained from implantation in rat abdominal
arteries. Chapter 5 summarizes the results and demonstrates the promise of this Zn-Li alloy
in bio-degradable coronary stent.

20

Chapter 1 Literature Review

1.1 Medical Problem and Stenting Technique
In 1977, Andreas Grüntzig performed the first balloon coronary angioplasty [18], which
advanced the technology of coronary stents. Stenting, clinically known as percutaneous
coronary intervention (PCI), has become a proven procedure for the treatment of arterial
occlusions. During stenting, one or more stent is delivered and placed into a narrowed
coronary artery by using a catheter system that is inserted into artery through a small
incision in the arm or groin. This approach reduces the early recoil and late vascular
remodeling that plagued balloon angioplasty treatment alone. Permanent metallic implants
presently consist of high-strength corrosion-resistant alloys such as stainless steel (316L)
and cobalt-chromium L605 (CoCr).
The drug-eluting stent (DES) approach was invented to mainly decrease the high rates of
restenosis and repeat revascularizations [19, 20]. It pioneered a new area for stents by
restoring blood flow via mechanical scaffolding and simultaneously releasing a
pharmaceutical agent that alleviates the restenosis response to the foreign stent material.
The reduction in restenosis of 60-80% across the board has driven its widespread
acceptance [21, 22]. However, further reports precluded the practices of DES on complex
subsets of patients and lesions, such as in tortuous vessels, small vessels, or long diffuse
calcified lesions; major adverse cardiac events were also found more frequent in the DES
group than in the bare-metal stent group (3.7% vs 1.0%) [23]. Moreover, concerns have
been raised over the long-term safety of first-generation DESs, which is remarkably
21

associated with an increased rate of adverse clinical events, particularly late-stage stent
thrombosis [24].

1.2 Absorbable Metal Stent (AMS)
1.2.1 The concept of AMS
Followed by decades of developing strategies to minimize the corrosion of metallic
biomaterials, there is now an increasing trend to use corrodible metals in medical
applications [25]. The AMS concept has been breaking this paradigm recently, with several
materials emerging as potential alternatives for vascular scaffolding that circumvent the
long term risks of permanent stents. Since the major effect of stent implantation is provided
by its scaffolding, it is required to be retained for 6-12 months during which arterial
remodeling and healing is completed [26]. After this period, the stent is preferred to be
broken down and excreted by the body. In pediatric interventions, which involves arteries
that have not completed their growth cycle, the disappearance of the stent will enable
natural vessel growth and will avoid the need for recatheterization and serial stent balloon
dilatation until adulthood. In the case of a fully absorbable stent, the problems of late stent
thrombosis and prolonged anti-platelet therapy are avoided. Thus, the development of biodegradable stents, which can fulfill the mission and step away, is the next logical
progression for the industry [3-5, 27].
Implantation of metallic stents is always accompanied by damage to the endothelial lining
and stretching of the vessel wall [28].
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Fig. 1.1. The schematic diagram of degradation behavior and the change of mechanical
integrity of AMSs during the vascular healing process.

As shown in Fig. 1.1, the injured vessels exhibit a wound healing response that can be
described in three overlapping phases: inflammation, granulation and remodeling [29]. For
zinc, an ideal middle ground between degradation and mechanical integrity during in vivo
implantations was observed [10]. Zinc corrosion begins at a very low degradation rate,
which is beneficial for this application as a zinc-based stent would maintain mechanical
integrity during arterial vessel remodeling. Thereafter, the degradation progresses while
the mechanical integrity decreases. Stent degradation ideally occurs at a sufficient rate that
will not cause an intolerable accumulation of degradation product around the implantation
site. A uniform corrosion mechanism is superior to localized corrosion in that the corrosion
begins from the surface to the bulk to maintain uniform mechanical integrity [30].
Localized corrosion such as pitting should be avoided since this could lead to the stent’s
cracking or fragmenting, ultimately ending with blood vessel injuries [30].
23

To date, no ideal bio-degradable stent has been invented. Depending on the lesion to be
treated, there is often a compromise of one or more of the above factors. For example,
stents with low surface area may not be very radio-opaque, while lesions requiring total
coverage may require stents having high surface area. In contrast to balloon angioplasty
where restenosis has been shown to be due to the combination of intimal hyperplasia,
vascular remodeling, and elastic recoil, restenosis after stenting is due solely to intimal
hyperplasia [31, 32]. The intimal hyperplasia relates to an exaggerated wound healing
response: smooth muscle cell migration, proliferation and extracellular matrix elaboration
mediated by the endothelial cell injury [33]. Because clinically used stents are permanent
implants, their presence may be a stimulus for prolonged inflammatory and foreign body
responses, which could potentially interfere with the wound healing response [28]. In
humans, the vessel wall healing process is usually complete between 3 to 6 months post
stenting. However, a foreign body response has been observed as late as 320 days post
implantation [34]. Studies aimed at improving current stent performance focused mainly
on drug-eluting stents.
1.2.2 The design of an ideal AMS
Theoretically, if all aspects of stent implantation are considered, the ideal stent should have
the following characteristics [28]:
•

Flexible - have the capacity to negotiate curved and tortuous coronary segments;

•

Radio-opaque - easily visible during angiography;

•

Low unexpanded profile - facilitates the passing and positioning of the stent in the
artery without predication with a balloon catheter;

•

Low roughness - minimize surface area for potential thrombogenic interactions;
24

•

Scaffolding effect - capacity to hold open the artery against the vessel wall's
constrictive tendencies (minimize recoil) and hold the stent at its selected
implantation site, for example, the tensile strength should be over 300 MPa,
elongation to failure should be over 15-18% and elastic recoil on expansion should
be less than 4%;

•

Show both blood and tissue compatibility;

•

Not induce an excessive inflammatory or neointimal response;

•

Intermediate corrosion rate - it should degrade with an appropriate rate so that the
loosing of the mechanical strength from the dissolution matches the supporting
function from tissue regeneration; and to make sure that the amount of the releasing
elements are tolerable to the human body [25]. It is believed that at least 6 months’
integrity is required. Complete degradation should occur after the vessel
remodeling process has finished.

1.2.3 Conventional metallic and polymeric AMS*
1.2.3.1 Current status
Bio-degradable stents are envisaged to support the arterial wall during the remodeling and
to degrade thereafter. Pure Fe was the first metal tested, although the majority of research
was done on Mg and its alloys. Over the past decade, Mg-based and Fe-based materials
have been well accepted and widely investigated for coronary stent applications.

*The material contained in this section was previously published in Advanced Healthcare
Materials by PK Bowen, ER Shearier, S Zhao, RJ Guillory, F Zhao, J Goldman, and J
Drelich, and is reproduced here with permission.
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Tremendous work has been focused on: (1) pure Mg and pure Fe and their alloying with
essential elements (Ca, Sr, Zn, Co, C and Si) or low toxic elements (Mn, Sn and Zr), and
the rare earth elements (Y and Gd) [35-41]; (2) novel structured bio-degradable metals
(porous, ultrafine, nanocrystalline and glassy structures) [42-44]; (3) surface modifications
by mechanical, chemical and electrochemical treatment [45, 46]; (4) animal testing and
clinical trial of AE21, WE43, Mg-based AMS and pure Fe stent/wires [5, 6, 14, 47-49]. All
those previous studies demonstrated that neither iron nor magnesium is ideal for stents.
Iron is considered as having a relatively low in vivo degradation rate. However, its
ferromagnetic nature constitutes a problem as an implantable device and it has also been
shown to produce a large volume of potentially hazardous iron oxide, which may not
degrade easily in the human body [49].
As for magnesium, it is less harmful but it degrades too fast (only 1-2 months) [10] and
also its ductility is very limited. Many attempts have been conducted to improve the
performance of Mg by alloying [64] and advanced processing techniques [63, 65]. For
example, it was demonstrated that alloying Mg with Li can change the crystal structure
from hexagonal to body-centered cubic (bcc), producing an increase in ductility, but in
exchange the UTS dropped to 132 MPa [50], much too low a value for a cardiovascular
stent.
The first implantation of Fe stents in the descending aorta of New Zealand white rabbits
demonstrated no significant inflammatory response, neointimal proliferation or systemic
toxicity [51]. Subsequent implantations of Fe stents in minipigs [52] and juvenile domestic
pigs [6] confirmed that Fe degrades without excess inflammation, local toxicity or
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thrombosis. Additionally, the high radial strength of Fe could make its stent struts thinner,
while a high ductility makes it easy to deliver via catheter-based systems [26]. However,
reports on Fe stents have indicated that it cannot corrode completely during the follow up
period [51]. In order to increase the degradation rate for Fe, tremendous work has been
focused either on the development of alloys or modification of the microstructure by heat
[53], mechanical [54] or solution treatment [41]. Another limitation for Fe stents comes
from the large volume of potentially hazardous iron oxide products, which may not degrade
easily in the human body [49]. Stainless steel 316 L (SS 316L) is included as the gold
standard metal for clinical stent applications. Alloying with manganese (Mn) [55] or electro
casting [56] was shown to increase the strength and degradation rate of pure Fe [55]. FeMn alloys [40, 41, 55, 57-59] exhibited similar mechanical properties to those of SS 316L.
The as-formed austenitic phase decreased the magnetic susceptibility which enhanced
compatibility with the magnetic resonance imaging (MRI). From biological facts, the
presence of Mn is more appropriate than nickel (used for the SS 316L), which is more toxic
and carcinogenic [60]. Electron casting and annealing at 550oC produced a fine grain
structure with an average grain size of 4 μm, resulting in a superior ductility and ultimate
tensile strength (UTS) [56].
Mg has been considered to be another attractive base-metal candidate because of its good
biocompatibility and low thrombogenicity [38, 61-63]. Mg alloys have a large range of
UTS and elongation, from 86 to 280 MPa and from 3% to 20%, respectively. However,
pure Mg usually corrodes too fast in aggressive chloride environments including body fluid
[63]. This fast degradation could not only make a Mg stent lose mechanical integrity in a
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short time, but also overload the tissue with degradation products that may lead to
neointimal formation [26].
Bio-degradable polymers have been tested for cardiovascular stent applications since the
late 1980s. Bio-degradable metals, although considered for implants much earlier (in XVII
century for Fe [77] and at the turn of the XIX century for Mg [78]), practically attracted
interest for cardiovascular applications at the beginning of XXI century. Pure Fe was the
first metal tested, although the majority of research was done on Mg and its alloys. As of
today only Mg-based and PLLA-based stents went beyond animal testing and were tested
clinically in humans (Tables 1.1 and 1.2).
To date, fully bio-degradable polymeric stent technology has progressed considerably
further relative to their more desirable metallic counterparts, [79] as summarized by data
in Table 1.2, with several devices having already obtained market approval in Europe or in
clinical trials.
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Table 1.1. Examples of pre-clinical and clinical tests on bio-degradable polymers and
metals
Implant
PLLA IgakiTamai stent (with
ST638 or ST494)
[66]

Implant Site and
Time
Porcine coronary
arteries, 21d

Major Test Results
Neointimal formation and geometric remodeling were
significantly less at the ST638-loaded stent site than at the
ST494 site.

Igaki-Tamai
stent [67, 68]

Human patient
artery, 6 months to
10 years

PLLA stent[69]

Porcine Coronary
Artery, 16 weeks

No stent thrombosis and no major cardiac event occurred
within 30 days. No major cardiac event, except for repeat
angioplasty, developed within 6 months. Long-term (>10 years)
clinical outcomes showed acceptable major adverse cardiac
events and scaffold thrombosis rates without stent recoil and
vessel remodeling.
Histological examination revealed no inflammation and
minimal neointimal hyperplasia

Rabbit aorta, 34
months

No inflammatory reaction observed after 6 months and it was
completely degraded by 24 months.

Copolymeric
polylactide
stent[70]

Pure Fe
stent [51]

Rabbits (descending
aorta), 6-18 months

The histomorphometric analysis at 3 weeks demonstrated
inhibition of neointimal formation by 53% with the paclitaxelloaded PDLLA when compared to the PDLLA stent, and by
44% when compared to metal stents.
No thrombogenicity, no significant neointimal proliferation and
systemic toxicity, faster degradation at junctions of the stent

Pure Fe stent
[52]

Porcine (descending
aorta), 360 d

Degradation product adjacent to the stent struts and within
adventitia accompanied by macrophages; no sign of toxicity

Paclitaxel-eluting
PDLLA[71]

Pure Fe stent [6]
Pure Fe wire [72]

Porcine coronary
arteries, 3 months

Pig coronary artery,
28d
Rat (artery lumen or
artery matrix), 1-9
months

Fe stent is very safe
Fe wire experienced substantial corrosion within artery matrix,
whereas it experienced minimal biocorrosion in bloodcontacting environment
Mg alloy is satisfactory; 40% loss of perfused lumen diameter
due to neointima formation; degradation time needs to be
extended
Mg alloy stents are safe and reliable; the struts are covered by
neointima after 6 d; higher minimal lumen diameter on week 4
and 12 than the 316L stent group

AE21[73] (Mg
alloy)

Pig (coronary
artery), 56d

WE43 [74] (Mg
alloy)

Minipig (coronary
artery), 56d

WE 43 [8]

Domestic (28d) or
minipigs Pig
(coronary artery, 3
months)

Degradation after 28 d post-surgery; less neointima compare to
316L stent;
stenosis increased from 28 d to 3 months; decreased lumen area

WE43 [75]

Domestic pig
coronary artery,28d

Reduced endothelial proliferation, presence of gas pockets

Mg stent [76]

Left pulmonary
artery of a preterm
baby patient, 5
months

Complete degradation occurred during 5 months; no in-stent
obstruction or neointimal hypertrophy was observed; the
degradation level was tolerated and the stent secured
reperfusion of the previously occluded left pulmonary artery.
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Table 1.2. Bio-degradable stents developed or under development (as per Iqbal et al. [80]
and Boland et al. [81]): a – with obtained market approval in Europe, b – used in preclinical trials, c – in clinical trials, d – discontinued
Stent

Material

Coating

Drug

Strut
thickness
[m]

Absorption
time
[month]

PLLA
PLLA
PLLA
PLLA
PLLA
PLLA
SA/AA
PTD-PC
PTD-PC
PTD-PC
PDLLA
PLLA
PLLA
PLLA,
PLDAECL

None
PDLLA
PDLLA
None
None
Salicylate
Salicylate
None
None
None
None
None
NA
NA

None
Everolimus
Everolimus
Everolimus
Myolimus
Sirolimus
Sirolimus
None
Sirolimus
NA
None
None
Sirolimus
EPC,
sirolimus

170
156
156
156
150
200
175
200
200
114-228
170
150-200
160
150

24
18-24
18-24
18-24
12-24
6-9
12
24
4-6
24
3-6
3-6
NA
NA

Mg alloy
Mg alloy
Mg alloy

None
None
PLLA

None
Paclitaxel
Sirolimus

165
120
125

<4
9
9

Polymeric
aIgaki-Tamai
dABSORB

BVS

1.0
aABSORB

BVS
1.1
aABSORB GT1
a
DeSolve
dIdeal BTI
pcIdeal BioStent
dREVA
cReZolve
cFantom
aART 18AZ
cFortitude
pcXinsorb
pcAcute BRS
Metallic
dAMS 1.0
dDREAMS-1
cDREAMS-2

This may be due to the pre-existence of numerous well-characterized Food and Drug
Administration (FDA) approved polymeric materials from which to manufacture a fully
bio-degradable polymeric stent, with the most frequently used polymer being PLLA [82,
83]. However, the recent ABSORB II trial [84]—which evaluated the performance of a
polymeric scaffold relative to a conventional metallic drug-eluting device—found poor
post-intervention luminal gains when polymeric devices were employed. This was due, in
part, to the reluctance of participating physicians to fully expand the brittle polymeric
material [85]. Furthermore, a 10-year follow-up with patients that had received an IgakiTamai PLLA coronary stent found poor tissue remodeling through histological analysis
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[86]. The area previously occupied by PLLA appeared to be filled with proteoglycan, a
component of extracellular matrix, but was acellular.
Bio-degradable polymeric materials have the developmental advantage of degrading
predominantly by a simple hydrolysis reaction, producing predictable degradation products,
and degrading through similar mechanisms whether evaluated in vitro or in vivo [87]. In
contrast, the development of a suitable metallic material for stenting applications, though
promising [73], has been elusive. This may be due to the lack of suitable pre-existing
materials, as well as the high cost and complexity of developing new materials. Metallic
materials often corrode via complex mechanisms that produce a wide range of products,
and the rates and products of corrosion can differ fundamentally between in vitro and in
vivo conditions [88-91]. This has made it difficult to translate success at the bench top into
a successful stent. Consequently, the scientific and industrial community has engaged in
more than a decade-long focus on Mg and Fe [92] that has failed to realize the promise of
acceptable fully bio-degradable metallic alternative to the emerging fully bio-degradable
polymeric stents.
1.2.3.2 Mechanical facts
Bio-degradable stents are designed to provide mechanical support for the arterial wall
during the remodeling period and to degrade with the progression of tissue regeneration
[30]. Ideally, in order to achieve the appropriate scaffolding, the mechanical properties of
the candidate materials should be close to those of 316L stainless steel, which has been
traditionally considered the gold standard material for stent constructs [93]. The stent
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material itself and its degradation products should also be non-toxic and compatible in the
cardiovascular environment [26].
The mechanical properties and degradation rates for polymers and metals tested for
cardiovascular stent applications are compiled in Tables 1.3 and 1.4. The mechanical
properties reported in these tables include elastic (Young’s) modulus (YM), yield strength
(YS), ultimate tensile strength (UTS) and elongation. These mechanical properties are
indicators of stent radial strength, acute and chronic recoil, axial and radial flexibility,
deliverability, profile and lifetime integrity [94]. The YM provides a measure of how well
the stent material resists deformation. Stents are typically delivered through a balloon
catheter and then expanded upon proper positioning in the artery. The stent material needs
to sustain deformations without cracking or fragmenting during delivery. The critical value
for the YM of materials used for stents is not well defined but it is preferable to have a high
value to reduce stent recoil.
Materials with a high UTS (>300 MPa) and low YS (~200 MPa) value are preferred for
the design of stents. A high UTS, combined with high YM, is needed to increase the stent’s
radial strength. A low YS is desirable for ease of crimping the stent onto a balloon tipped
catheter and then expanding the stent at low balloon pressures during deployment. A YS
that is too high can trigger acute recoil during or after balloon deflation. Unfortunately,
most of the materials with high UTS also have a high YS. Many polymers do not exhibit
a proportional limit in tension and so YS is often not reported. As shown in Tables 1.3 and
1.4, the UTS values for metals are superior to those of polymers.
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Table 1.3. Mechanical and degradation properties of polymers tested for cardiovascular
stent applications [68, 95] (The values heavily depend on the molecular weight and
should be treated as approximate values only.)
Polymer

PLLA
PGA
PDLLA
PCL
TD-PCP [96]

Melting
Young
Point
Modulus
o
[ C]
[GPa]
170-180
2.8-4.0
225-230
>7.0
amorphous 1.4-2.7
55-65
0.2-0.3
290-320
-

Ultimate
Tensile
Strength
[MPa]
50
55
10
10-30

Elongation
[%]
5-10
15-20
3-10
300-500
10-13

Degradation
Time
[month]
>24 [68]
6-12
12-16
>24
7

Additionally, the YM value should be as high as possible to prevent acute recoil, and elastic
recoil of stent on expansion should be below 4%. Poncin and Proft additionally suggest
using the YS/YM ratio in characterizing the elastic range of materials, which provides an
indication of the expected recoil upon deflation of the balloon [110]. This value is between
0.16 and 0.32 for stainless steel and cobalt alloys used in manufacturing of permanent
stents. Bio-degradable stent materials should probably have similar YS/YM values. Both
UTS and elongation to failure influence fatigue resistance and fracture toughness of the
stents. An elongation of 30% or higher is typically preferred in materials used for stent
design, although the acceptable criterion often reported is >15-18%.
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Table 1.4. Mechanical and degradation properties of Fe and Mg and their alloys tested
for cardiovascular stent applications

Material

Metallurgy

SS316L [97]
Armco Fe [98]
Fe-35Mn [55]
Fe-10Mn-1Pd
[58]
Fe-21Mn-0.7C1Pd [99, 100]

annealed
annealed
annealed
heat-treated
heat-treated

Grain
size
[μm]

YM
[GPa]

YS
[MPa]

UTS
[MPa]

Elongation
[%]

DR
[mm/year]

Iron and Iron Alloys
12-30
193
190
40
200
150
<100
230
85060
950
69050-100
1095

490
200
430
14501550
10201320

40
40
30

0.20
0.44

2-8

-

24-48

0.21

Fe [56]

electrocasted
annealed at
550oC

2-8

54

270

290

18

0.46-1.22

Alloyed Fe with
(Mn, Co, Al,
W, Sn, B, C
and S) [40]

as rolled

100400

-

390450

520860

5-10

0.09-0.19

Nanocrystalline
Fe [54]

Equal
channel
angular
processing

0.080.20

-

-

250450

-

0.09-0.2

13

407

Pure Mg [53]
WE43 alloy
[101]
AM60B-F [53,
101, 102]
AZ91D [88,
101]
AZ31 [101,
103]
ZW21 [26, 104,
105]
WZ21 [26, 104,
105]
Mg-Zn [61,
106]
Mg-Zn-Mn
[101, 107]
Mg-Ca [101,
108, 109]

as cast

Magnesium and Magnesium Alloys
41
20
86

extruded T5

10

44

195

280

2

1.35

die cast

25

45

-

220

6-8

8.97

die cast

-

-

150

230

3

2.80

extruded

-

45

125135

235

7

1.17*

extruded

4

-

200

270

17

-

extruded

7

-

140

250

20

-

extruded

-

42

170

280

19

0.16

extruded

-

-

247

280

22

0.92*

extruded

-

-

136

240

11

1.71

*the degradation rate for AZ31 and Mg-Zn-Mn is from in vivo test, others are calculated from potentiodynamic
polarization test.
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The minimum lifetime before failure of permanent stents made of 316L stainless steel is
10 years, which translates to ~400 million cycles. The same criteria do not apply to
absorbable stents; at present, there is no standard defined for this new generation of
cardiovascular stents. Since a bio-degradable stent needs to retain its mechanical integrity
for 3 to 6 months, the stent material should be acceptable if it is able to sustain ~10 to 20
million cycles before failure occurs.
Despite the increased challenges faced in their development, metallic materials hold
several important advantages over polymeric materials. Metallic stents are considered to
be superior to polymeric devices in terms of mechanical performance (i.e. ultimate tensile
strength elastic range [94]) and ease of translation to a clinical environment. Their greater
mechanical strength and better elastic properties are more similar to traditional metallic
stents and permit a greater flexibility in stent designs and a wider range of expandable
diameters during deployment. The reduced radial strength and ductility of polymeric stents
have necessitated substantially larger struts (which have the side effect of increasing
vascular injury and blood flow disruptions) and the introduction of a locking mechanism
to maintain luminal cross sectional area following deployment [111]. The larger polymer
stents require a larger catheter for delivery relative to metal stents, which may exclude
pediatric populations [112]. The larger stent struts may also increase susceptibility to early
and midterm thrombosis [113]. The locking mechanism further constrains stent design
flexibility and the freedom to control the final stent diameter during deployment. It may
also be a concern from a device safety standpoint, as this complex feature may increase the
risks of device failure. Even in a successful deployment, lower material ductility may also
affect the clinician’s willingness to expand a polymer stent sufficiently to completely
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overcome recoil and achieve full deployment. This effect was hypothesized to have led to
significantly lower post-procedure luminal gains with a polymeric stent relative to a
metallic stent in the Absorb II clinical trial [114, 115].
As compared to polymers, Fe- and Mg-based metallic absorbable scaffolds:
•

exhibit similar radial force to stainless steel [53] and cobalt chromium stents [6];

•

display the superior profile of metallic scaffolds, which makes them more
deliverable [116]; and

•

can bioabsorb at comparable rates with arterial remodeling and wound healing [53].

1.2.3.3 Biocompatibility and corrosion facts
Mechanical strength similarity to conventional stents allows clinicians to have reasonable
deployment expectations when using a bio-degradable metallic stent. The potentially
beneficial bioactivity of corrosion products [117] raises the exciting prospect that
pathogenic cell responses to stent implantation may be modulated as the stent corrodes.
Therefore, the ability to control corrosion rates and behavior by conventional metallurgical
and alloying approaches may allow for corrosion product-mediated reprogramming of host
responses near the host-implant interface. As of today, only stents made of Mg alloys have
been reported to go through clinical trials.[79] The first design of Mg-based stents from
Biotronik (AMS-1.0), composed of about 93 wt.% of Mg and 7 wt.% of rare earth elements,
degraded in electrolyte solutions in about 60 days [80]. Although the degradation rate was
too high, pre-clinical studies indicated a rapid endotheliazation [118]. Clinical studies on
63 patients confirmed the stent’s safety, with no cardiac death, myocardial infarction, or
thrombosis, although the target lesion revascularization was ~24% and ~27% at 4 and 12
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months, respectively [119]. Improved metallic stents from Biotronik (DREAMS-1 and
DREAMS-2) utilize the Mg-alloy exhibiting a slower degradation rate and improved radial
strength than what was used for AMS-1.0. DREAMS-1 additionally incorporated antiproliferative drugs to reduce neointimal hyperplasia and prevent restenosis. DREAMS-2 is
an improved version of DREAMS-1 that instead of incorporateing drug into a porous
structure of metal, is additionally covered with a drug-eluting PLLA thin coating.
Immunosuppressive and antiproliferative drug prevents restenosis, whereas PLLA reduces
the stent’s degradation rate at the early stage.
Biocompatibility and corrosion facts of degradable alloys and polymers are listed in Table
1.5. For bio-degradable metals, the released metallic ions may induce local and systemic
toxicity to host cells. Therefore, the overall amount of the element used to design a final
device and the local release rate for each ion during degradation should be carefully
examined. The degradation mode for polymers seems less harmful, but its in vivo long term
overdose effects should not be neglected. A possible cause for concern for polymers is a
recent report that a degraded Igaki-Tamai polymer stent was replaced with proteoglycans
[86]. This may indicate poor extracellular matrix regeneration within the footprint of a
PLLA stent. Poor matrix regeneration may be a consequence of the mode of polymer
degradation vs. that of metals, which proceeds by a bulk degradation that may produce
voids inside the material vs. surface corrosion taking place directly at the tissue-metal
interface, which allows for an expansion of the tissue front directly into the degrading
implant footprint.
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Table 1.5. Key properties and aspects of potential bio-degradable metals and polymers
for cardiovascular stent applications [120]
Fe-alloys

Mg-alloys

Polymers

Yes

Yes

No

6-20 mg

375-500 mg

-

5.0-17.6 g/l

0.73-1.06 mM

-

In vivo long
term overdose
effects

Damage of lipid
membranes, proteins and
DNA;
Stimulus for
inflammations;
Increase of free radicals.

Excessive Mg leads to
nausea;
Reduction of the
excitability of
neuromuscular,
smooth muscular and
cardiac regions.

Adverse tissue
reactions;
Inflammatory tissue
reactions, necrosis
and aneurysms.

Effect on local
pH during
degradation

Alkalescent

Alkalescent

Acidic

Corrosion mode

Localized corrosion

Mostly localized and
pitting

Hydrolytic
(volume) or
enzymatic (surface)

None

Hydrogen

None

Fe(OH)2, α-FeO(OH),
Fe3O4

Mg(OH)2, MgO,
MgCl2, (Ca1Mg
x
x)10(PO4)6OH2

Water soluble and
non-soluble
oligomers

Essential trace
element
Recommended
daily intake
Blood serum
level

Expected
gaseous
corrosion
products
Expected solid
corrosion
products

1.3 Zn-based stent: An innovative solution for bio-degradable stent
With the purpose of searching for suitable alloying elements, Song [64] explored in vitro
corrosion rates of several magnesium alloys in 2007, pointing out that Ca, Mn and Zn could
be appropriate candidates. Zinc, as one of the most abundant nutritionally essential
elements in the human body [9], began to be studied as an alloying element or biodegradable material. Zhang [61] studied the binary Mg-6Zn magnesium alloy which
showed reduced corrosion rate, good biocompatibility in vivo and suitable mechanical
properties. In 2011, Vojtech D et al. [121] prepared binary Zn-Mg alloys containing Mg
content up to 3 wt.%, and found that the addition of 1 wt.% Mg significantly improved the
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mechanical properties of pure Zn from 30 MPa (UTS) to 110 MPa (UTS). They also
indicated that pure Zn and binary Zn-Mg alloys exhibited close corrosion rates (~0.0180.145 mm/yr), which were significantly lower than those of Mg and AZ91HP alloys.
Recently Bowen et al. [10] examined the in vivo corrosion behavior of pure zinc for the
first time and concluded that unlike iron, the corrosion of pure zinc does not produce a
potentially hazardous product. Zinc also corrodes much slower than magnesium (4-6
months), indicating the best aspect of zinc in AMS field [10]. One major concern for a pure
zinc stent is the low tensile strength (only 120 MPa) and zinc might not be strong enough
to hold open human arteries. Material used for the stent needs to have the tensile
strength >200 MPa, preferentially close to 300 MPa [122]. Improvements in mechanical
properties of zinc can be approached through either manipulation of metal micro-/nanostructure [123, 124] or alloying [121].
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Chapter 2 Objectives and Hypotheses

2.1 The proposed Zn-Li alloy in stent application
The early use of lithium was as a hardener in aluminum-alloy bearing materials in the 1960s
[1-3]. The aging and mechanical properties in ternary and more complex alloy systems
were extensively studied at the beginning, due to the great desire of high-strength alloys
for operation at room and elevated temperatures in the Soviet Union and abroad. Zakharov
and Fridlyander showed the favorable effect of lithium on the mechanical properties of
aluminum alloys [3, 4]. Later Drits noted that alloying of Al-Zn-Mg alloys with small
amounts of lithium (less than 0.75%) could not only increase the strength properties but
also reduce the softening of the alloy on aging at high temperatures and long times [5].
The illumination of adding lithium into zinc to improve the stent largely comes from the
positive sides of magnesium alloy LAE442 that has 4 wt.% of lithium, 4 wt.% of
aluminium and 2 wt.% of rare-earth elements. LAE442 has been tested as non-allergic [6],
bio-degradable, which exhibits slow and regular degradation without the formation of
radiographic gas [7, 8], and is widely considered as the most promising bio-degradable
implant for orthopedic use [7, 9].
Previous reports on small additions of lithium to bio-degradable alloys include LAE 442,
which contains 4 wt.% of lithium and demonstrated good biocompatibility when implanted
to the New Zealand rabbit [7]. After three months, it degraded very regularly (4.7 ± 0.1
mm2) with volume loss of ~46%. No clinical intolerances were found during the 12 month
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implantation [7]. It can also be estimated that Li-Zn alloys could slow down the corrosion
rate, which means the Zn-Li alloys could probably remain intact in vivo for more than 4
months as compared to the pure zinc.
In terms of clinical feasibility, lithium was detected in human organs and fetal tissues
already in the late 19th century, leading to early suggestions of possible specific functions
in the organism [10]. Animal studies have demonstrated that Li plays a role in the
expansion of the pluripotential stem cell pool to more mature progenitor cells and blood
elements [10, 11]. In lithium deficient rats, behavioral abnormalities and a significant
negative effect on litter size and litter weight at birth were observed [10]. In lithium
deficient goats the conception rate was reduced, gravid lithium deficient goats experienced
a higher incidence of spontaneous abortions [10]. In humans, the fact that lithium can calm
the highs of mania and lift the lows of depression has been known for more than 60 years
[11]. It is the only medication that reduces the risk of suicide in bipolar patients and it is
inexpensive. However, there are the side effects such as tremors, frequent urination, thyroid
problems, weight gain, or even kidney failure if overdosed because the toxic dose of
lithium is only about two to three times higher than its therapeutic dose [11].
The toxic potential of a zinc-lithium stent should be negligible. A cut, polished alloy stent
may comprise, to a first approximation, ~50 mg of the pure metal. Assuming complete
degradation within one year, the expected daily dose of elements are estimated here (shown
in Table 2.1), which are far below the daily body consumption allowance [10].
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Table 2.1. Released amount of elements from the stent should be below a daily body
consumption allowance
Intake
Zn
Li

Daily Allowance for
Adult males
10 mg [12]
0.6 mg [10]

*Estimated release from
Zn-Li alloy
<140 µg
< 1 µg

(*The daily amount of release can be obtained by dividing the mass of Zn and Li into 365
days. For alloy Zn-14 at.% Li, if assuming the stent is 50 mg, then the total mass of Li is
0.38 mg so the daily release of Li into biological system is 1 µg).

2.2 Objectives
The objectives of this Ph.D. research include (Fig.2.1):
•

to produce a new Zn-Li alloy system with superior mechanical properties and to
understand its phase constitutions, microstructure evolutions and mechanical properties
with changing composition; then select for the optimum compositions for in vitro and
in vivo experiments;

•

to simulate the degradation behavior of the Zn-Li alloy in vitro and explore the relations
between corrosion rate, corrosion products and surface morphology with changing
compositions;

•

to show the potential of the Zn-Li alloy in stent application by investigating the
degradation mechanism, the rate of bioabsorption, biocompatibility, cytotoxicity and
corrosion product migration in vivo using a rat model.
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Fig. 2.1. Research flowchart for the Zn-Li system in this proposal

2.3 Hypotheses
Hypothesis I: The increase of Li from 2% to 6 at.% would increase the mechanical
strength of the Zn alloy while retaining suitable ductility due to the intermetallic
precipitation hardening.
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Fig. 2.2. Phase diagram of Zn-Li (Retrieved from the ASM Phase Diagram database)

Based on the binary phase diagram (Fig.2.2) and the compositions we chose, the final
product could be a Zn-rich solid solution and the LiZn4 intermetallic. In solid solutions,
lithium solute atoms can either sit in substitutional or interstitial positions. The solute atoms
cause lattice distortions that impede dislocation motion, increasing the yield stress of the
Zn-Li alloys [13]. Increasing the concentration of the lithium atoms will increase the yield
strength of zinc while retaining its ductility due to the intermetallic precipitation hardening
[14]. However, there could be a limit to the amount of solute that can be added before a
second phase is created [13]. Once above this limit concentration, adding more lithium will
cause the formation of a second phase. The Zn-Li alloys that compose the second phase
precipitates act as pinning points in a similar manner to solutes. If the precipitated atoms
are small, the dislocations would cut through them. As a result, new surfaces of the particle
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would get exposed to the matrix and the particle-matrix interfacial energy would increase;
for larger precipitate particles with further additions, looping or bowing of the dislocations
would occur which result in longer dislocations [15]. The interaction of precipitated
intermetallics with the dislocations could hinder the propagation of dislocations and result
in the increase of strength [15]. We hope to establish some relations between the volume
fractions of the intermetallics and the mechanical strength.
Another possible strengthening mechanism here is the texture strengthening. In that case,
randomly oriented grains would slip on their appropriate glide systems and rotate from
their initial conditions, and a strong preferred orientation develops so that certain slip
planes tend to align in the direction of rolling [16]. This texture phenomenon depends
heavily on the compositions and it happens only when 8 at.% or more lithium is added into
the Zn system.
The study of lattice parameters of solid solutions, evolution of microstructures, the
volumetric fractions of intermetallics and the texture transformations at different
compositions could help us understand the physiochemical characteristics of this alloy
system. This could give us direction on if or how the alloying of lithium strengthens zinc,
providing a basis for selecting the optimum alloy compositions needed for the in vitro and
in vivo corrosion testing.
Hypothesis II: The Zn-Li alloy will exhibit near ideal corrosion behavior like pure Zn, and
the corrosion rate of Zn-Li alloy will increase a bit with addition of Li according to the
relationship: 𝐶𝑜𝑟𝑟𝑜𝑠𝑖𝑜𝑛 𝑅𝑎𝑡𝑒 = 𝑓(𝑖𝑐𝑜𝑟𝑟 ).
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With uniform distribution of anodic/cathodic reactants, corrosion reactions would proceed
in a uniform manner which would result in the uniform loss of dimension. As mentioned
in Hypothesis II, micro-galvanic corrosion could be one of the leading corrosions.
Therefore, if small and finely dispersed intermetallic phases are distributed uniformly in
the metal matrix, micro-galvanic corrosion would happen everywhere and macroscopically
uniform corrosion can be achieved. It should be noted that corrosion also depends on the
biological environment. In vitro testing fluid consisting of inorganic ions contributes to the
formation of mineral-like corrosion layers; while the in vivo environment carries organic
components such as proteins and cells which might lead to a high nitrogen level in the
corrosion layer [17].
In relation to the corrosion rate of most implant materials, electrochemical techniques are
used in view of their sensitivity. The most common method of corrosion rate determination
for slowly corroding materials is based on the determination of the polarization resistance
Rp (ASTM G59).
𝑅𝑝 =

𝜕∆𝐸

Eq. 2.1

𝜕𝑖
𝐵

𝑖𝑐𝑜𝑟𝑟 = 106 × 𝑅𝑝

Eq. 2.2

𝑏 𝑏

𝑎 𝑐
𝐵 = 2.303(𝑏
+𝑏
𝑎

Eq. 2.3

𝑐)

𝐶𝑜𝑟𝑟𝑜𝑠𝑖𝑜𝑛 𝑅𝑎𝑡𝑒 = 3.27×10−3

𝑖𝑐𝑜𝑟𝑟 𝐸𝑊
𝜌

Eq. 2.4

(where icorr defined as corrosion current density, mμA/cm2; ba and bc are Tafel constants
obtained from the anodic and cathodic polarization measurement, V; EW the equivalent
mass of corroding species, g; ρ is the density of corroding material, g/cm3).
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The corrosion rate of Zn-Li alloys could increase with increasing lithium content: 1) as the
lithium is very active, so increasing addition of lithium may increase the activity of the zinc
alloys and shift the corrosion potential to more negative values; 2) as we observed from
XRD, more lithium would increase the amount of LiZn4 intermetallics. The intermetallic
phases would act as a cathode and the Zn matrix act as the anode, which could generate
micro-galvanic corrosion. The increased presence of intermetallic phases may lead to the
formation of more galvanic cells so that the galvanic corrosion could be enhanced and more
severe corrosion would occur; 3) however the increased incorporation of lithium into solid
solutions or redundant lithium around solid solutions may reduce the corrosion rate-as they
can also decrease the potential differences at the interfaces of phases and matrix. The study
of solubility of lithium could help understand this effect.
Hypothesis III: Zn-Li alloys will exhibit desirable biocompatibility and a benign/stable
cellular response in vivo.
Previous studies with Zn wires within the abdominal aorta demonstrated excellent
biocompatibility [18]. At 2.5 months the Zn wire was completely neo-endothelialized with
a thin layer of endothelial cells. There was no significant inflammatory response, intimal
hyperplasia, or localized necrosis over 6.5 months. These findings indicate that Zn may
suppress localized cellular activity that contributes to the thickening of the neo-intimal.
To explore the biocompatibility of alloy wires, both 4N Zn and Zn-Li alloy wire samples
with diameter of 0.25 mm and length of 2 cm were punched into the abdominal aorta and
then directed into the lumen for 10 mm before exteriorization. In this case, wires were
immersed in the flowing blood to mimic the environment of a stent strut. After 2-12
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months, rats were euthanized and rat aortas containing the wire implants were harvested.
The wires had not become dislocated from their implant location at the time of collection.
To preserve the corrosion layer, explanted wires were preserved in 200 proof ethanol.
The leftover wires with aortas were snap-frozen in liquid nitrogen and cryo-sectioned for
histological analysis [19]. Before staining, samples were preserved in a -80 oC freezer.
Cross sections were ethanol fixed and then stained with hematoxylin and eosin (H&E),
mounted in Permount solution and imaged using an Olympus BX51, DP70 bright-field
microscope.
The neointimal tissue with smooth muscle cells and inflammatory cells were inspected
around the implants; variations of cell densities in the artery wall, lumen interface and
biocorrosion area were measured.
The in vivo biocompatibility study of this system would help show the promise of Zn-Li
alloy as a cardiovascular stent.
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Chapter 3 Results and Discussions: Structural characteristics
and in vitro biodegradation of a novel Zn-Li alloy prepared by
induction melting and hot rolling*

Abstract
Zinc shows great promise as a bio-degradable metal, however, the low tensile strength of
pure zinc limits its application for endovascular stent purposes. In this study, a new Zn-xLi
alloy (with x=2, 4, 6 at.%) was prepared by induction melting in an argon atmosphere and
processed through hot rolling. Structures of the formulated binary alloys were
characterized by x-ray diffraction and optical microscopy. Mechanical testing showed that
the incorporation of Li into Zn increased ultimate tensile strength from <120 MPa (pure
Zn) to >560 MPa (x=6 at.%). In vitro corrosion behavior was evaluated by immersion tests
in simulated body fluid. The Zn-2Li and Zn-4Li corrosion study demonstrated that
corrosion rates and products resemble those observed for pure Zn in vivo, and in addition,
the Zn-4Li alloy exhibits higher resistance to corrosion as compared to Zn-2Li. The
findings herein encourage further exploration of Zn-Li systems for structural use in
biomedical vascular support applications with the ultimate goal of simplifying stent
procedures thereby reducing stent related complications.
Keywords: Zn-Li; microstructure; strength; elongation; in vitro biodegradation

*The material contained in this section is previously published at Metallurgical and
Materials Transactions A by S Zhao, C T. McNamara, N Verhun, J P. Braykovich, J
Goldman, and J Drelich, and is reproduced here with permission.
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3.1 Introduction
Bio-degradable stents are envisaged to support the arterial wall during remodeling after
stent deployment and to degrade harmlessly thereafter. This new generation of
endovascular stents may eliminate the potential for chronic inflammation [1] and
thrombosis risks [2] of permanent stents. They could also alleviate the repetition of
invasive procedures when stenting at the same site in the event of restenosis [3]. Over the
past decade, polymeric and metallic materials have been widely investigated for
endovascular stent applications with very limited success [4-7]. The previous reports
demonstrated that neither polymers nor metallic candidates such as iron and magnesium
are ideal for bio-degradable stenting applications due to either poor mechanical properties
[7-10], incomplete bioabsorption of corrosion products [11], or premature degradation [12].
Consequently, the search for new bio-degradable materials continues [7].
Zinc is one of the most abundant nutritionally essential elements in the human body [13]
and studies have been initiated examining zinc as a bio-degradable material in recent years
[14]. One major concern regarding the use of a pure zinc stent is the material’s low intrinsic
ultimate tensile strength (UTS) of about 120 MPa or less, where the cardiovascular stent
application requires a material with UTS closer to 300 MPa [15]. Improvements in
mechanical properties of zinc can be approached through alloying [16, 17] and
manipulation of metal micro-/nano-structure [18, 19]. Lithium is one of the few elements
with significant solubility in zinc, and Zn-Li is therefore among a few potentially agehardenable systems.
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Fig. 3.1. Zinc-lithium phase diagram (prepared based on Ref.[20])

Hypoeutectic 2 at.% Li (0.2 wt.%), eutectic 4 at.% Li (0.4 wt.%) and hypereutectic 6 at.%
Li (0.7 wt.%) compositions were chosen for this study based on the phase diagram
produced by Pelton [20] (Fig.3.1). The eutectic reaction under the casting conditions used
herein is expected to result in prolific lamellar formation during cooling, so that much of
the available Li is consumed and the only Li available for post-solidification strengthening
is what is left in supersaturation upon cooling below the eutectic temperature in (Zn)Li
regions. Therefore, precipitation hardening is expected to play a major role in the 2%, a
minor role in the 4%, and a negligible role in the 6% alloy. However, the LiZn4 formed as
part of the lamellar structure does have an impact on yield and ultimate strength as the
shear moduli between this and the Zn(Li) phase is different, and the strength increment is
proportional to 1/λ1/2, where λ is the lamellar spacing, according to a Hall-Petch relation.
This effect is expected to play a major role in the 6% alloy, a minor role in the 4%, and a
negligible role in the 2% alloy. Strengthening from further grain size refinement is also
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possible since the recrystallization from hot rolling may produce a finer structure than the
as-cast material in all three alloys, although grain size is not explicitly measured here. Work
hardening is not anticipated to play a role in these tensile or hardness tests as the alloys
here are annealed directly following the hot-rolling process, which is intended to reduce
stored dislocation energy while precipitating as much LiZn4 as possible. If crystalline slip
becomes too difficult because of the aforementioned obstacles to dislocation motion during
loading of an HCP crystal, deformation via twinning mechanisms may be activated which
allow deformation through much larger scale atomic rearrangements.
An endovascular metallic stent weighs approximately 50 mg [14]. If it degrades completely
within one year, the expected daily dose of Zn and Li would be below 140 and 1 µg,
respectively, for an alloy containing 14 at.% Li (Table 3.1). These values are roughly two
orders of magnitude below the daily bodily consumption allowances [21, 22] and thus the
toxic potential of a zinc-lithium stent is anticipated to be negligible in terms of the overall
quantities of the elements released.
Table 3.1. Estimated daily release of Zn and Li from a 50 mg stent compared to daily
bodily consumption allowances
Intake
Zn
Li

Daily Allowance for
Adult males
10 mg [22]
0.6 mg [21]

*Estimated release from
Zn-Li alloy
140 µg
1 µg

(*The daily amount of release can be obtained by dividing the mass of Zn and Li assuming
a full degradation timeframe of 365 days. For an alloy of Zn-14 at.% Li and a stent mass
of 50 mg, the total mass of Li is 0.38 mg so the daily release of Li into biological system
is 1 µg).
With regard to local toxic effects, rapid transport of ions in vascular tissue [23] would
prevent elemental enrichment and cytotoxicity in the implant’s vicinity [10]. Lithium has
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been successfully used in bio-degradable Mg alloy LAE442 which has 4 wt.% of lithium,
4 wt.% of aluminm, and 2 wt.% of rare-earth elements. LAE442 has been shown to be nonallergenic [24], bio-degradable, and to degrade more slowly than pure magnesium without
the formation of radiographically oBEIrvable gas [25, 26] and with a more uniform
degradation behavior [26]. It has been considered as the most promising implant material
for orthopedic use [27].
Based on this evidence, alloying zinc with lithium is expected to produce a stent material
with favorable biocompatibility and reasonable strength. To our knowledge, no systematic
research has been reported on the Zn-Li alloy as a bio-degradable implant material. Most
of the existing studies in the binary Li-Zn system focus on thermodynamic properties [20],
the crystal structures of LiZnx compounds [28], preliminary charge-discharge
characteristics [29], and the reactivity of lithium-ion batteries [30]. In the rechargeable Liion battery area, the Li-Zn alloys have been considered as an alternative to graphite-based
anode materials [28]. As for the five binary Li-Zn intermetallic phases, LiZn was
considered to be crystalize in the NaTi structure type [31], and LiZn4 was proposed to have
a Mg-type structure with a random distribution of Li and Zn [32]. Crystal structures of
Li2Zn3 at low and high temperature modifications were determined by single-crystal X-ray
diffraction techniques in 2012 [33]. The structures of Li2Zn5 and LiZn2 phases remain
unexplored.
This new series of bio-degradable Zn-Li alloys is formulated, cast, and processed through
hot rolling in this study to simulate commercial processes such as extrusion. The alloys are
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characterized regarding their as-processed tensile properties and degradation in simulated
body fluid.

3.2 Materials and methods
3.2.1 Alloy preparation
Pure Zn (99.99 wt.%, Alfa Aesar company, Ward Hill, MA) and pure Li foil (99.9 wt.%,
Alfa Aesar company, Ward Hill, MA) were loaded into a graphite crucible in an inertatmosphere glove box to avoid atmospheric oxidation of lithium.

Fig. 3.2. Fabrication of Zn-Li ingots, strips, and dogbone tensile bars; a-c. vacuum
induction melting set-up for alloy ingots; d. uniaxial rolling process for reduce ingots
from 1.8mm to ~300µm; e. layout of Japax wire EDM g-code for precision cutting of
dogbone tensile bars.
A custom vacuum induction melting setup at Michigan Tech (Fig.3.2a-c) was used to
fabricate the Zn-Li alloys. They were cast by induction melting with a power of ~3 kW
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under a 0.9 atm argon atmosphere. The ultimate vacuum level was 2 ×10-4 torr. A stepper
motor controlled by a custom LabView (National Instruments, Austin, TX) script tiltpoured the melt into a 50 mm diameter stainless steel mold. These ingots were squared and
sectioned to a size of 35×35×60 mm and underwent deformation processing via hot rolling
to simulate the extrusion process used in conventional stent tube forming. Before rolling,
alloys were placed in a box furnace at 662°F (350°C) for several minutes until reaching the
furnace temperature. The rolling process was performed on a Fenn (Newington, CT) 2high mill equipped with 133 mm rolls at 42 rpm (Fig.3.2d).
After three passes through the rolling mill, the sample thickness was recorded and the
sample was returned to the furnace for 3 mins. The final sheet was reduced from 35 mm to
approximately 300 μm in thickness for a total reduction of cross-sectional area of 99%.
From these sheets, dogbone tensile bars were cut for standard tests per ASTM E8/E8M-11
using wire electro discharge machining (wire EDM) on a PC-controlled Japax Lux-3
(McWilliams EDM, Brighton, MI) (Fig.3.2e).

3.2.2 Alloy characterization
Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES) (PerkinElmer
Optima 7000DV, Waltham, MA) was utilized in detecting the compositions of Zn alloy
sheets after hot rolling. To produce a solution suitable for ICP-OES analysis, 250 mg of
each alloy was dissolved in 40 ml of 6M HCl, which was diluted for analysis.
Microscopy samples of both as-cast and hot-rolled material were mounted in epoxy and
polished with 600-grit, 800-grit, and 1200-grit silicon carbide. Final polishing steps were
performed using 6 μm, 1 μm and 0.1 μm diamond cloth and 0.05 μm alumina slurry on
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microfiber. Microstructure of alloys were recorded using a Leica EC3 (Leica Microsystems;
Buffalo Grove, Illinois) digital camera on an Olympus PMG-3 metallograph (Olympus,
Shinjuku, Tokyo, Japan).
X-ray diffraction (XRD) was performed on an XDS2000 θ/θ X-ray diffractometer (Scintag
Inc., Cupertino, CA) with CuKα radiation (k = 1.540562 Å). The scans were performed
continuously from 20° to 100° in 2θ at a speed of 0.6°/min with a step size of 0.02°.
Uniaxial tensile tests were performed using an Instron 5984 electro-mechanical testing
machine equipped with a 150 kN load cell (Instron, Norwood, MA). All tests were
performed at an initial strain rate of 10-3 s-1.
Vickers microhardness (HV) was measured using an M-400-G1 digital hardness tester
(LECO, St Joseph, MI) at a load of 200g for 5 s and a minimum of 10 indentations per
sample.
Electrochemical measurements were made with a PARSTAT 4000, teamed with the Versa
Studio software package (AMETEK/Princeton Applied Research, Berwin, PA). The
PARSTAT 4000 is a potentiostat/galvanostat combined with a frequency response analyzer
(FRA) contained in a single unit. A three-electrode set-up was employed: the working
electrode (Zn-Li coupons, immersed area of 1 cm2) with Ag/AgCl (SSE) and graphite as
the reference and counter electrodes, respectively. The test medium was simulated body
fluid in a 98.6°F (37°C) incubator with 5% CO2 supply, the composition of which is
discussed below and also given in Table 3.2.
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Table 3.2. Ion concentrations of human blood plasma and the experimental simulated
body fluid (SBF)
Ion

Blood plasma

Simulated Body Fluid [34]

Revised
Simulated Body
Fluid

Na+

142.0

142.0

160.0

K+

5.0

5.0

4.0

2+

1.5

1.5

1.0

Ca2+

2.5

2.5

2.5

Cl-

103.0

148.8

142.0

27.0

4.2

26.0

HPO4

1.0

1.0

1.0

SO42-

0.5

0.5

0.5

pH

7.2-7.4

7.4

7.4

Mg

HCO32-

3.2.3 In vitro immersion test and characterization of corrosion product
In vitro corrosion tests were carried out in modified simulated body fluid (SBF). In contrast
with the classic tris-buffered (trishydroxymethyl-aminomethane) SBF solution, the content
of bicarbonate was elevated to the level found in blood plasma; conveniently, the buffering
function of tris was accomplished by the additional bicarbonate. The adoption of this
bicarbonate buffering system was important, as it resembles the in vivo environment of the
acid-base homeostasis of a living host, including the human body. Ion concentrations of
the modified SBF used here, traditional SBF [34], and human blood plasma are listed in
Table 3.2.
The rolled alloy sheets of 300 μm thickness were cut into 1×1 cm squares. Pure Zn was
also used here as control. In vitro submersion took place in 50 ml centrifuge tubes, where
the coupons were covered with 40 ml of SBF medium and placed in an incubator at 98.6°F
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(37°C) and 5% CO2 atmosphere for 4, 7, and 14 days. The ratio of solution volume to
specimen area (V/S) was ~20 ml/cm2, which was suggested by the ASTM G31-72 to ensure
the volume is large enough to avoid medium changes during corrosion [35]. The pH was
measured at 7.2-7.4 throughout the experiment.
Although ISO 10993-15:2000 recommended a V/S ratio of less than 1 ml/cm2, various V/S
ratios ranging from 0.33 ml/cm2 [36] to 7375 ml/cm2 [37] have been chosen by researchers.
It is difficult to specify a standard V/S for all immersion tests since the ratio should be
based on the implantation environment the researchers intend to mimic [38]. Therefore,
even for the same alloy from different research groups, the in vitro corrosion results are
not compared [38]. It is known that in vitro methods are quick and relatively inexpensive,
but it’s also apparent that predicting in vivo behavior from in vitro testing can be misleading
[37]. Local pH, impurities, processing, the concentration of the pitting anion [39] and
proteins [40] can all play a role in metallic corrosion.
Surface morphological and elemental analyses were carried out on the samples following
in vitro corrosion using a JSM 6400 scanning electron microscope (SEM) (JEOL, Peabody,
MA) equipped with an energy dispersive spectrometer (EDS). The accelerating voltage and
working distance used for all samples was 20 kV and 39 mm, respectively. Fourier
Transform Infrared Spectroscopy (FTIR) was conducted in diffuse reflectance mode with
a Genesis II FTIR spectrophotometer (SUNY Genesso, Genesso, NY). A series of 1024
scans was performed at 1 cm-1 resolution from 400 to 4000 cm-1.
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3.3 Results and Discussion
3.3.1 Elemental analysis
Experimental compositions of the alloys are given in Table 3.3. For all three Zn-Li alloys,
the experimental compositions from ICP-OES were slightly lower than the nominal
compositions. Ni and Fe were detected as trace impurities from Zn; Ni remained below
the detection limit for the three alloys and Fe concentration was also very low.
Table 3.3. ICP-OES compositional analysis of rolled Zn alloys
Li/at.%

Li/at.%

Nominal

Experimental

Zn

<0.01

Zn-2Li

Sample ID

Fe/at.%

Ni /at.%

Zn/at.%

<0.01

<0.01

<0.10

Bal.

2.00

1.10

0.03

<0.10

Bal.

Zn-4 Li

4.00

3.20

0.01

<0.10

Bal.

Zn-6 Li

6.00

5.50

0.01

<0.10

Bal.

3.3.2 XRD analysis
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Fig. 3.3. XRD patterns of as-cast and hot rolled alloys with different compositions

XRD patterns for Zn-xLi (x=2, 4, 6 at.%) before and after hot rolling are shown in Fig.3.3.
All the investigated samples exhibit dual-phasic character with the main phase of zinc and
minor phase of LiZn4. Patterns were collected at room temperature, and the LiZn4 phase
present in all as-cast and as-processed material is assumed to be of the low-temperature α70

variety as all cooling was done slowly in air to allow the eutectoid relaxation to occur. For
the as-cast samples, peaks corresponding to Zn are high and narrow, indicating relatively
large grain sizes and very little lattice deformation. Peaks corresponding to the intermetallic
phase LiZn4 in as-cast samples have the highest relative intensities in the Zn-4Li alloy with
peaks from sets of (101), (002), and (100) planes, indicating prolific nucleation and growth
of LiZn4 during solidification at this composition.
After hot rolling, the rolling direction-transverse direction (RD-TD) cross sections are
examined and the preferential orientation of LiZn4 and the Zn lattice change as observed
by the increased intensities of the (002) and (001) peaks relative to the (101) peak for the
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Fig. 3.4. Full scan range XRD patterns of hot rolled alloys with different compositions.
LiZn4 peaks are identified.
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Peaks corresponding to LiZn4 also increase in intensity relative to those for the Zn lattice
with the increase of Li due to larger volume fractions of LiZn4 available in the more
concentrated alloys (Fig.3.4). Minor peaks at 2θ=21.7o and 89.9o are observed which do
not correspond to known reflections in the JCPDS-ICDD database. In order to determine
if these peaks originate from the Zn+LiZn4 mixture, an estimation of the structure factor
(F) using these two phases was carried out using Equations 1-3 with results displayed in
Table 3.4.
Table 3.4. Structure factors for ordered and disordered states of Zn(Li)+LiZn4
h

k

l

2θ

Sin/λ

fLi

fZn

|F|2

|F|2

(disordered)

(ordered)

0

0

1

22

0.24

1.65

20.5

0

1076

0

0

2

42

0.43

1.20

15.5

2556

615

0

0

3

64

0.58

0.82

12.5

0

399

0

0

4

89

0.65

0.70

11.5

1396

349

1

0

1

43

0.44

1.15

15.0

448

571

1

0

0

37

0.39

1.30

15.8

166

639

1) If disordered (i.e. solid solution):

1

2

1

2

1

3

𝐹 = 2×𝑓𝑎𝑣𝑒 [(𝑒 𝑖2𝜋(3ℎ+3𝑘+4𝑙) + 𝑒 𝑖2𝜋(3ℎ+3𝑘+4𝑙) ]
4

1

𝑓𝑎𝑣𝑒 = 5 ×𝑓𝑍𝑛 + 5 ×𝑓𝐿𝑖

Eq. 3.1
Eq. 3.2

2) If ordered (i.e. dual-phasic):
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1

𝐹 = 2× 5 𝑓𝐿𝑖 𝑒

1
3

2
3

1
4

4

𝑖2𝜋( ℎ+ 𝑘+ 𝑙)

+ 2× 5 𝑓𝑍𝑛 𝑒

2
3

1
3

3
4

𝑖2𝜋( ℎ+ 𝑘+ 𝑙)

Eq. 3.3

The theoretical values of 2θ at (00l) planes (Table 3.5) are then obtained from:
𝜆2

𝑎2

𝑠𝑖𝑛2 𝜃 = 4𝑎2 (ℎ2 + 𝑘 2 + 𝑙 2 𝑐 2 )

Eq. 3.4

where LiZn4 has the structure P63/mmc (no. 194, HCP) with a = 0.27702(8) and c =
0.43785(9) nm.

Table 3.5. Theoretical and experimental values of 2θ for h=k=0 and l=1, 2, 3, or 4
(hkl)

2 θ (Theoretical)

2 θ (Experimental)

001

21.80

21.70

002

41.46

41.40

003

63.71

×

004

89.94

89.95

The matching of the theoretical 2θ values from structure factor calculations with
experimentally observed diffraction peaks indicates that the two unidentified peaks do
originate from the Zn+LiZn4 structure but are not tabulated in the current database. In a
previous study on α-LiZn4 powder [30], a structural model was determined in which both
Zn and Li were seated in the (1/3, 2/3, 1/4) 2c site with a Li/Zn ratio equal to 0.28
(experimental value). This phase was isostructural with elemental HCP Zn, consistent with
the findings of the current study. It is concluded that hot rolling both promotes precipitation
of the ordered LiZn4 phase and produces texture in which the matrix and the LiZn4 phase
both have preferred orientations with the c-axis normal to the RD-TD plane. Interestingly,
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no occurrence of the (003) reflection was observed in Ref. [28] or the present study, though
this is an allowable reflection based on the structure factor equations above for the dualphasic approximation. This could suggest a different arrangement of Zn and Li atoms in
the LiZn4 phase, or the peak intensity could simply be below the resolution limit of the
XRD and filtered out of the spectrum.
3.3.3 Microstructural features
a

b

c

e

f

150 μm

d

Fig. 3.5. Optical micrographs of as-cast (a-c) and hot-rolled (d-f) Zn-Li alloys with Li
content increasing from 2 to 4 to 6 at.% from left to right. The scale bar in panel a.
applies to all 6 micrographs.

Optical micrographs from RD-TD cross sections of alloy sheets before and after hot rolling
are shown in Fig.3.5. Microstructures are consistent with Scheil/Scheil-Gulliver
nonequilibrium solidification conditions. For Zn-2Li, small amounts of Zn+LiZn4 are
present in the α-Zn matrix. With Zn-4Li, a mixture of lamellar Zn+LiZn4 grains and α-Zn
grains is observed. The lamellae are observed in grains with apparently random orientation.
For Zn-6Li, dendritic arms and trunks are observed consisting of Zn+LiZn4 which have a
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very tight lamellar spacing with interdendritic channels of Zn(Li). The random
arrangement of grains observed in the hypoeutectic alloy tended towards directional
solidification with increasing Li content. The fact that pro-eutectic grains of α-Zn are
observed for Zn-4 at.% Li in Fig.3.5 points to a slightly lower experimental composition
than 4 at.% Li in this cross-section. This is confirmed by ICP-OES results, shown in Table
3.3.
After the hot rolling and annealing process, the Zn-4Li and Zn-6Li samples exhibit severe
rolling texture and no occurrence of equiaxed grains; dendrite arms and trunks are refined
and the grain width decreases from ~50 μm to ~10 μm. In contrast, the hypoeutectic alloy
exhibits equiaxed grains almost exclusively. This oBEIrvation points to dynamic
recrystallization occurring during the hot rolling process or static recrystallization
afterwards for this alloy but not for the higher Li alloys. However, the texture that develops
during rolling is retained: the XRD scans in Fig.3.3 show an increase in the intensity of the
(100) peak relative to the (101) for all three alloys.
For all alloys here, the high-temperature intermetallic phase β-LiZn4, present in both
lamellar structures and as precipitated particles, relaxes to the room-temperature α-LiZn4
phase at the eutectoid temperature of 65 oC [20]. Evidence of this reaction was not observed
metallographically, and it is assumed that all β-LiZn4 converts to α-LiZn4 with ease.
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3.3.4 Mechanical testing
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Fig. 3.6. Ultimate tensile strength (UTS), yield strength, and elongation to failure of Zn2Li, Zn-4Li, and Zn-6Li with error bars representing standard deviation in measurement

Yield strength, UTS, and ductility values for all tested alloys are shown in Fig.3.6. The 300
MPa UTS and 200 MPa yield strength benchmarks for bio-degradable stent materials [14]
are exceeded at all alloying levels. Higher contents of Li give higher tensile strengths due
to the larger volume fractions of the LiZn4 phase. Ductility of the Zn-2Li and Zn-4Li alloys
are favorable compared to very limited ductility of Zn-6Li in view of benchmark values of
15-18% elongation to failure for bio-degradable stent materials [14]. While these are
excellent properties for a stent material, further study is needed to delineate the exact
strengthening mechanisms operating in each alloy. Based on these empirical strength and
ductility values, alloys with lower content of Li (2 and 4 at.%, nominally) were selected
for in vitro corrosion testing.
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Fig. 3.7. Vickers microhardness of hot rolled and as-cast alloys with different
compositions.

As shown in Fig.3.7, the hardness of Zn-2Li increases from 85±6 to 98±6 after hot rolling,
and Zn-4Li and Zn-6Li increase from 98±6 to 115±6 and 115±8 to 136±9, respectively.
This is a 15% percent increase in hardness for Zn-2Li and 18% for Zn-6 at.%. This can
attribute to precipitation strengthening through the formation of LiZn4, evidenced by XRD,
and boundary strengthening by the highly refined grain structure (Fig.3.5). Zn-6 at.% has
the finest grains (only a few microns in width) and the highest volume fraction of LiZn 4;
this combination gives the highest hardness and the strengthening effect from hot-rolling
is more evident. An increase in dislocation density is highly probably following a 99%
reduction in area, but much of the hardening effect is likely lost during the postdeformation recovery anneal. Texture effects might also play a role in this system as some
preferential orientation of LiZn4 was detected in Fig.3.3, which may lead to anisotropy in
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mechanical properties as a consequence of the limited number of slip systems available in
Zn.
3.3.5 Corrosion rate in SBF
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Fig. 3.8. Potentiodynamic curves of different alloys after immediate immersion in SBF
medium

For the investigated Zn-Li alloys and pure Zn, the approximate values of corrosion
potential and corrosion current were determined from Tafel slopes [41]. In order to estimate
the corrosion current values, the anodic curve was extrapolated until it intersected with the
level of corrosion potentials as shown in Fig.3.8 and Table 3.6. A high current density
(current on the surface) at the corresponding potential indicates a high corrosion rate of the
alloy. Comparison between the Zn-Li alloy curves with pure Zn shows that the alloys with
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2 and 4 at.% Li have similar curves. The corrosion rates of the various tested materials are
estimated (Table 3.6, column 3) through Tafel extrapolation.
Table 3.6. Corrosion potentials, corrosion current densities and corrosion rates, obtained
from the polarization curves, for Zn, Zn-2Li, and Zn-4Li
Sample

Ecorr / V vs. SCE

icorr / (μA/cm-2)

Corrosion Rate /(μm/year)

Zn

-1.35

0.88

13

Zn-2Li

-1.18

3.43

50

Zn-4Li

-1.21

0.73

10

The Zn-4 at.% Li alloy exhibits the lowest current density (0.73 μA/cm2) and therefore the
highest resistance to corrosion compared to the other two samples. The corrosion resistance
could due to the formation of a protective passive layer, typically the surface-product
surface film (Fig.3.8). The thicker the passive layer and better attachment to the surface,
the higher the corrosion resistance of alloy.
Corrosion rates were estimated in terms of penetration rate (CR) using the Faraday’s law:
𝐶𝑅 = 𝐾1
𝐸𝑊 =

𝑖𝑐𝑜𝑟𝑟
𝜌

𝐸𝑊

1

Eq. 3.5
Eq. 3.6

𝑛 𝑓
∑ 𝑖 𝑖
𝑤𝑖

where: CR is in mm/yr, icorr in μA/cm2, K1=3.27×10-3 mm·g/μA·cm·yr, 𝜌 =density in g/cm3,
EW is the equivalent weight of the alloy, fi =the mass fraction of the ith element in the alloy,
wi= the atomic weight of the ith element in the alloy, and ni= the valence of the ith element
of the alloy.
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According to the calculation results summarized in Table 3.6, penetration rates for Zn-Li
alloys in SBF are 50-60 μm⋅yr-1, and are comparable to Zn studied in plasma (10 μm⋅yr-1)
[26], whole blood (50 μm⋅yr-1) [26], and in vivo (20-50 μm⋅yr-1) [10].
3.3.6 Morphology and EDS of corrosion products

Fig. 3.9. SEM micrographs of Zn-Li surfaces after immersion in SBF. From row A to C,
Li increases from 0 to 2 to 4 at.%; from column 1 to 2, immersion period increases from
4 to 14 days.
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Images of corroded surfaces are shown in Fig.3.9 for Zn, Zn-2Li and Zn-4Li after
immersion in SBF for 4 and 14 days. At the 4 day time point, Zn and the two alloys exhibit
morphologically different surface deposits. The initial products formed on the Zn substrate
comprised sharp elongated crystals, and flower-like and porous aggregates (Fig.3.9-A1).
The Zn-2Li substrate displays a finer initial crystal network and is decorated with
agglomerated clusters on top in light contrast (Fig.3.9-B1). The Zn-4Li substrate is covered
with sponge-like structures embedded with regular spheres and irregular aggregates
(Fig.3.9-C1). After 14 days immersion, the three samples appear very similar with each
substrate coated in a regular and well-defined population of spherical particles with average
diameter of roughly 1 μm in all cases (Fig.3.9-A2, B2, C2).
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Fig. 3.10. EDS spectra of Zn-Li alloy surface products after immersion in SBF for 14
days

To gain a first approximation of the elemental compositions of the particles formed on the
sample surfaces during the immersion testing, EDS analysis of some of the sample surfaces
(Fig.3.10) was performed. These scans confirmed the presence of Ca, P, and O, suggesting
that the particles could be mainly composed of calcium phosphate, similar to what was
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found in a previous study on Mg in vivo [42], although with a much different morphology
here.
2.2

2.4

(a)

(b)

Zn-2Li
PO4

2.0

2.2

Zn-4Li

3-

3-

PO4

2.0

OH

Absorbance /a.u.

Absorbance/a.u.

1.8

3-

PO4

1.8

3-

PO4
-

1.6
14d
1.4

14d

OH

1.6

-

-

OH

7d
1.4

4d

7d
1.2

4d

1.2

0d

2-

1200

1000

800

Wavenumber/cm
4.4

2-

CO3

1.0

CO3

1.0

0d

-1

14d

4.2

600

1000

400

3-

(c)
3-

PO4

3.8

Absorbance/a.u.

-1

PO4

4.0
3.6

500

Wavenumber /cm

OH

Zn-4Li

-

3.4
3.2
3.0
2.8
2.6

Zn-2Li

2.4
2-

2.2
2.0
1.8

CO3
Zn

1.6
1000

500

Wavenumber/cm

-1

Fig. 3.11. FTIR spectra after 14 days immersion in SBF for Zn, Zn-2Li, and Zn-4Li

To determine the phase composition and functional groups among the different alloys after
immersion testing, FTIR analysis was employed. In the FTIR spectrum (Fig.3.11), the
PO43- group band is observed at 570 cm-1, which is related to asymmetric deformation
modes of ν4 group; the absorption band in the range of 1040-1090 cm-1 is characteristic of
the asymmetrical stretching mode of ν3 group. The locations of absorption bands for PO43group and OH- at 631 cm-1, combined with the decrease of Ca2+ in SBF medium confirmed
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through ICP-OES testing, explicitly indicates the formation of hydrated apatite phases in
the corroded alloys. Absorption intensity of PO43- group and OH- group (Fig.3.11a, b)
increases with prolonged immersion time, which may indicate improvement of apatite
properties making this phase more stable. Presence of CO32- bands in pure Zn after 14 days’
immersion (Fig.3.11c) is identified at 875 cm-1, corresponding to ν2 stretching mode of
CO32-. This indicates the possible formation of a calcite phase after immersion, while this
peak is missing from both Zn-Li alloys.

3.4 Conclusions
By using a vacuum induction melting technique, a new class of Zn-Li alloys has been cast,
hot rolled, and analyzed for biomedical-focused application. XRD results indicate the
formation of LiZn4 through the emergence of diffraction peaks corresponding to (001) and
(004) for this phase when deformed by hot rolling, which increased hardness significantly
in all cases. Mechanical testing showed that alloying Zn with Li increases the tensile
strength to 360 MPa with a nominal addition of 2 at.% and 560 MPa with 6 at.% Li
following hot rolling. Addition of Li above the eutectic composition caused a severe
decrease in elongation to failure making the 6% Li alloy unsuitable for cardiovascular stent
application.
Our in vitro study with the newly formulated Zn-2Li and Zn-4Li alloys demonstrates that
the corrosion rates and products in modified SBF solution closely resemble that of pure Zn
observed in vivo, in plasma, and in whole blood from previous studies. The Zn-4Li alloy
exhibited higher resistance to corrosion compared to Zn-2Li suggesting a positive effect of
Li content on protective characteristics of the corrosion layer.
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Chapter 4 Results and Discussions: Zn-Li Alloy after
Extrusion and Drawing: Structural, Mechanical
Characterization, and Biodegradation in Abdominal Aorta of
Rat*

Abstract
Zinc shows great promise as a bio-degradable metal. The implantation of pure Zn into the
abdominal aorta of Sprague-Dawley rats exhibited an optimal corrosion rate and
biocompatibility for endovascular applications. However, the low tensile strength of zinc
remains a major concern.
A cast billet of the Zn-Li alloy was produced in a vacuum induction caster under argon
atmosphere, followed by a wire drawing process. Two phases of the binary alloy identified
by x-ray diffraction include the zinc phase and intermetallic LiZn4 phase. Mechanical
testing proved that incorporating 0.1 wt.% of Li into Zn increased its ultimate tensile
strength from 116 ± 13 MPa (pure Zn) to 274 ± 61 MPa while the ductility was held at 17
± 7%.

*The material contained in this section is previously published at Materials Science and
Engineering: C by S Zhao, J M. Seitz, R Eifler, H J. Maier, R J. Guillory II, E Earley, J
Goldman, and J Drelich, and is reproduced here with permission.
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Implantation of 10 mm Zn-Li wire segments into abdominal aorta of rats revealed an
excellent biocompatibility of this material in the arterial environment. The biodegradation
rate for Zn-Li was found to be about 0.008 mm/yr and 0.045 mm/yr at 2 and 12 months,
respectively.

Keywords: Zn-Li; bio-degradable; in vivo biodegradation

4.1 Introduction
Followed by decades of developing strategies to minimize the corrosion of metallic
biomaterials, there is now an increasing trend to use absorbable metals in medical
applications [1]. The concept of absorbable metals stents (AMS) was envisaged to treat the
disease of artery occlusions and then disappear harmlessly when they are no longer needed
as mechanical scaffolding. Since the major effect of stent implantation is provided by its
scaffolding, it is required to be retained for 6-12 months during which time arterial
remodeling and healing is completed [2]. After this period, the stent is preferred to be
broken down and excreted by the body, leaving behind a natural functioning artery. The
advances of AMS for vascular scaffolding may allow for circumventing the long term risks
of permanent stents, such as chronic inflammation, late stage thrombosis (clotting) and
stent strut disruption (fracture) [3]. In pediatric intervention, which involves arteries that
have not completed their growth cycle, the disappearance of the stent would enable natural
vessel growth and avoid the need for recatheterization and serial stent balloon dilatation
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until adulthood [4]. Thus, the development of bio-degradable stents, which can fulfill the
mission and step away, is the next logical progression for the industry [5-7].
Mg-based and Fe-based materials have been widely investigated as potential base materials
in recent years due to their biocompatible elements and mechanical characteristics [2, 810]. However, previous corrosion studies with bare Mg- and Fe-based metals demonstrated
that the in vivo degradation performance cannot satisfy the requirement for the coronary
stent yet. Tremendous work on improvement has been focused on: (1) pure Mg and pure
Fe and their alloying with essential elements (Ca, Sr, Zn, Co, C and Si) or low contents of
toxic elements (Mn, Sn and Zr), and the rare earth elements (Y and Gd) [11-17]; (2) novel
structured bio-degradable metals (porous, ultrafine, nanocrystalline and glassy structures)
[18-20]; (3) surface modifications by mechanical, chemical and electrochemical treatment
[21, 22]. Presently, with the exception of the limus-eluting bio-degradable magnesium
scaffold introduced in 2016 by Biotronic, these modifications have not resulted in a biodegradable metallic stent with clinical success.
With the purpose of searching for suitable alloying elements, zinc as one of the most
abundant nutritionally essential elements in the human body [23] began to be studied as an
alloying element or bio-degradable base material [24]. In 2011, Vojtech et al. [25] prepared
binary Zn-Mg alloys containing Mg content up to 3 wt.%, and found that the binary ZnMg alloys exhibited corrosion rates (≈ 0.018 mm/yr) close to pure Zn, which were
significantly lower than those of Mg and AZ91HP alloys. As a breakthrough, Bowen et al.
[26, 27] examined the corrosion behavior of pure Zn for the first time and found that 1) Zn
exhibited excellent biocompatibility after resided in the arterial lumen of
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Sprague-Dawley rats for 6.5 months; 2) the corrosion products are not potentially
hazardous like those of iron; 3) the corrosion rate in the first 2-3 months is very close to
the ideal degradation rate for medical implants (0.02 mm/y) [28] and followed by an
acceleration in 3-6 months; 4) a uniform corrosion is detected in earlier months so that the
corrosion is more or less uniformly distributed over the entire exposed surface and the
corrosion proceeds at approximately the same rate over the exposed metal surface [29]. All
these corrosion characteristics of pure Zn suggest that Zn arterial corrosion behavior may
be superior to other explored materials in the AMS field [24, 27]. The major concern for a
pure Zn stent is that the tensile strength is relatively low (80 - 120 MPa). Stent materials
used to prop open the lumen of arteries needs to have a tensile strength of at least 200 MPa,
preferably close to 300 MPa [30]. Improvements in mechanical properties of Zn can be
obtained through manipulation of its microstructure [31, 32] or alloying [25].
Zn-Li is one of a few potentially age-hardenable systems due to the significant solubility
of lithium in zinc [33]. The in vivo studies of LAE442 (4 wt.% of lithium) confirmed
suitability of this implant material for orthopedic use [34]. Additionally, lithium was
approved by the U.S. Food and Drug Administration (FDA) as a drug in the early 1970s to
treat manic depression [35]. It has also been reported to be beneficial in treatments of brain
injury, stroke, Alzheimer’s, Huntington’s, and Parkinson’s diseases, amyotrophic lateral
sclerosis (ALS), spinal cord injury, and other conditions [35]. However, the drug’s
therapeutic window is very narrow and an overdose of lithium may induce tremors,
frequent urination, thyroid problems, weight gain, and kidney failure [36]. Clinical
experience with lithium suggests that its effective dose range is 0.6-1.0 mM serum level
(500-1200 mg of lithium per day) while toxic levels occur at 1.2 mM or greater [35]. The
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U.S. Environmental Protection Agency (EPA) in 1985 recommended the daily lithium
intake of a 70 kg adult to range from 650 to 3100 μg [37]. Our previous estimates of the
Zn-Li system indicated that [33]: 1) the overall quantities of lithium released from a zinclithium stent (with 0.7 wt.% of Li) is two orders of magnitude below the daily bodily
consumption allowances; and 2) the incorporation of Li into Zn would increase the ultimate
tensile strength (UTS) from < 120 MPa (pure Zn) to > 560 MPa (6 at.% Li).
However, an excessive content of Li lowers the ductility significantly due to the larger
volume fractions of the LiZn4 phase. To maintain applicable ductility and sufficient
strength for the cardiovascular stent application, the addition of Li should remain below 4
at.% (0.4 wt.%).
Novel Zn-Li alloy wires (with 0.1 wt.% of Li) were prepared in this study. Metallurgical
characterizations, in vivo biodegradation and in vivo biocompatibility analysis of the ZnLi wire were carried out. The present body of work aimed at retaining corrosion behavior
suitable for bio-degradable stent application, yet improving the mechanical and corrosion
uniformity characteristics.

4.2 Materials and methods
4.2.1 Materials
Prior to casting, Zn shot (99.99+ wt.%, Alfa Aesar company, Ward Hill, MA), Zn foil (99.9
wt.%, Alfa Aesar company, Ward Hill, MA) and Li foil (99.9 wt.%, Alfa Aesar company,
Ward Hill, MA) were weighed using a laboratory balance located in an inert-atmosphere
glove box to avoid oxidation of Li. The total Zn shot and Zn foil weighed 1.0 kg, while the
Li foil weighed 2.2 g. The Li foil was then wrapped tightly inside the Zn foil to form a
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charge. The combined material was then sealed inside a sequence of three plastic specimen
bags before being removed from the glove box. The Zn-Li foil charge and the Zn shots
were immediately loaded into a graphite crucible. A custom vacuum induction melting
setup at Michigan Tech was used to fabricate the Zn-Li alloys. They were cast by induction
melting with a power of ≈ 3 kW under a 0.9 atm argon atmosphere. The temperature was
set to be slightly above the melting point of Zn, 419.5 oC for a few minutes. The ultimate
vacuum level was 2 ×10-4 torr. A stepper motor controlled by a custom LabView (National
Instruments, Austin, TX) script tilt-poured the melt into a 25 mm diameter stainless steel
mold. 4N Zn wire (99.99+ wt.%, Goodfellow Corporation, Oakdale, Pennsylvania) was
utilized as control samples.
4.2.2 Manufacture of Zn-Li wires
The Zn-Li alloy was further processed following a hot extrusion process employing a 10
MN extruder (SMS MEER GmbH). Prior to the extrusion, the Zn-Li billets possessing a
diameter of 25 mm were heated to a temperature of 200 °C and the extruder’s recipient was
heated to 210 °C. In order to reduce the extrusion ratio, a die with four 0.5 mm in diameter
openings was used for extrusion. Extrusion of the billets was carried out with a ram velocity
of 0.1 mm/s (Fmax = 4.1 MN) resulting in four Zn-Li rods, each with a diameter of 0.5 mm.
The extrusion ratio is 625 due to the four openings in the die. Cooling of the rods was
allowed at RT.
Subsequent wire drawing was carried out at a temperature of 180 °C by means of a selfconstructed drawing machine at Leibniz Universität Hannover. Multiple drawing passes
were used to reduce the wires’ diameters to 0.25 mm. The drawing dies opening diameters
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used for the drawing sequence were: 0.477 mm, 0.435 mm, 0.362 mm, 0.330 mm, 0.274
mm and 0.250 mm. Annealing or other heat treatment procedures were not required
between the particular drawing passes.
4.2.3 Material characterizations
Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES) (PerkinElmer
Optima 7000DV, Waltham, MA) was utilized in detecting the compositions of Zn alloy
wire after drawing. To produce a solution suitable for ICP-OES analysis, 80 mg of alloy
wire was dissolved in 12 ml of 6M HCl, which was diluted for analysis.
The Zn-Li sections were positioned in epoxy in order to obtain both the longitudinal
(parallel to the extrusion or rolling direction) and transverse (perpendicular to the extrusion
or rolling direction) view of each material. Mounted wires were ground with 600-grit, 800grit, and 1200-grit silicon carbide. Final polishing steps were performed using 6 μm, 1 μm
and 0.1 μm diamond cloth and 0.05 μm alumina slurry on microfiber. Microstructure of
alloys were recorded using a Leica EC3 (Leica Microsystems; Buffalo Grove, Illinois)
digital camera on an Olympus PMG-3 metallograph (Olympus, Shinjuku, Tokyo, Japan).
The polished wire sections were also carbon-coated and imaged with a JSM 6400 scanning
electron microscope (SEM) (JEOL, Peabody, MA). The accelerating voltage and working
distance used for SEM were 15 kV and 39 mm. Elemental contrast from the alloy surface
was assessed from the collected backscattering electrons.
X-ray diffraction (XRD) was performed on an XDS2000 θ/θ X-ray diffractometer (Scintag
Inc., Cupertino, CA) with CuKα radiation ( = 1.540562 Å). The scans were performed
continuously from 35° to 45° in 2θ at a speed of 0.2°/min with a step size of 0.02°.
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Uniaxial tensile tests were performed using a Bose ELF 3200 mechanical tester (Bose Inc.,
MN, US). Prior to the test, wires were mounted on two polycarbonate (PC) holders using
Loctite General Purpose epoxy (Henkel Corporation; Westlake, OH). The gauge length
was set to be 10 mm. A small load cell (max. load: 22.2 N) was used, and the relative
displacement and the strain rate were 12mm and 0.01 mm/sec. Yield stress, tensile stress,
elongation to failure were calculated from the stress-strain curves. Standard deviation was
estimated from eight 4N Zn and five Zn-Li wires. The ductility in % area reduction was
also estimated by measuring the area reduction at the fracture based on four different wires.
Vickers microhardness (HV) was measured using an M-400-G1 digital hardness tester
(LECO, St Joseph, MI) at a load of 200 g for 5 s and 18 indentations per sample. Standard
deviation was estimated from eighteen different points from the longitudinal section of a
4N Zn and a Zn-Li wire.
Area fraction and average particle size of the intermetallic phase were determined using
the ImageJ software. The volume fraction of precipitation phase was calculated as the sum
of areas of all black particles divided by the total area of the image. The average area of
precipitates was calculated as the sum of the area of precipitates divided by number of
particles. The average particle size was calculated from this average area assuming
spherical geometry.
4.2.4 Arterial implantation
The primary method of this in vivo evaluation was based on a Sprague Dawley rat (Harlan
Labs) model [38]. All animal tests have been approved by the animal care and use
committee (IACUC) of Michigan Technological University. 4N Zn and Zn-Li alloy wire
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samples with diameter of 0.25 mm and length of 2 cm were punched into the abdominal
aorta and then directed into the lumen for 10 mm before exteriorization. In this case, wires
were immersed in the flowing blood to mimic the environment of a stent strut. After 2-12
months, rats were euthanized and rat aortas containing the wire implants were harvested.
The wires had not become dislocated from their implant location at the time of collection.
To preserve the corrosion layer, explanted wires were preserved in 200 proof ethanol.
4.2.5 Biodegradation analysis
Part of the corroded wires were mounted in epoxy and cut transversely to expose the cross
section. Wire mounts were ground with 800 grit SiC, 1200 grit SiC, 6 μm diamond and 1
μm alumina and then cut into slices with thickness of 1 mm to fit into an aluminum mount
with carbon tape. The wire cross section was coated with thin layer of carbon before
imaging with the scanning electron microscope. Imaging of the wires was conducted at 15
kV accelerating voltage with a reduced working distance of 12 mm using a backscattered
detector. Cross sectional area (CSA) analysis of the backscattered image were conducted
using ImageJ software (Fig.4.5a) [39]. The penetration rate was determined according to
the following equation:

Penetration rate (μm/yr) =

𝑁𝑜𝑚𝑖𝑛𝑎𝑙 𝐶𝑆𝐴
𝑀𝑒𝑡𝑎𝑙𝑙𝑖𝑐 𝐶𝑆𝐴
−√
𝜋
𝜋
𝐶𝑜𝑟𝑟𝑜𝑠𝑖𝑜𝑛 𝑇𝑖𝑚𝑒
360

√

Eq. 4.1

Elemental mappings of Ca, P, C, Cl, Zn, O from cross sections were captured to signify
the corrosions using an environmental scanning microscope (FEI Philips XL 40). The
accelerating voltage and working distance were 15 kV and 10 mm.
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FT-IR was conducted in diffuse reflectance mode with a Jasco FTIR-4200
spectrophotometer. A series of 64 scans were performed at 4 cm-1 resolutions from 800 to
2000 cm-1.
4.2.6 Histological evaluation
The leftover wires with aortas were snap-frozen in liquid nitrogen and cryo-sectioned for
histological analysis [38]. Before staining, samples were preserved in a -80 oC freezer.
Cross sections were ethanol fixed and then stained with hematoxylin and eosin (H&E),
mounted in Permount solution and imaged using an Olympus BX51, DP70 bright-field
microscope.
The neointimal tissue with smooth muscle cells and inflammatory cells were inspected
around the implants; variations of cell densities in the artery wall, lumen interface and
biocorrosion area were measured.
4.2.7 Statistical analysis
All quoted errors and error bars correspond to the sample standard error.

4.3 Results
4.3.1 Material characterizations
Experimental composition of Zn-Li and purity of 4N Zn are given in Table 4.1. For this
Zn-Li alloy, the experimental composition for Li is 0.1 wt.%. Cu, Mg, Fe and Pb were
detected as trace impurities from Zn; and Cd, Al and Ni remained below the detection limit.
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Table 4.1. ICP-OES compositional analysis of Zn-Li wires (wt.%)
Sample

Li

Cu

Mg

Fe

Pb

Cd

Al

Ni

Zn

4N Zn

<0.001

<0.003

<0.002

<0.002

<0.001

<0.001

<0.001

<0.001

Bal.

Zn-Li

0.103

0.003

0.002

0.002

0.001

<0.001

<0.001

<0.001

Bal.

b

a

100 μm

c

100 μm

d

c

3
30 μm

30 μm

Fig. 4.1. SEM secondary electron (a, c) and backscattered electron images (b, d) for the
surfaces of as-received Zn-Li wires

Surface images in Fig.4.1(a, c) exhibited severe rolling texture and precipitates. The
darkest phase (representing the lowest atomic number) from the BEI images in Fig.4.1(b,
d) indicate the occurrence of spherical and ribbon-like precipitates. This could be the Lirich phase.
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Fig. 4.2. Optical microscopy images of the Zn-Li wire (Ø = 0.25 mm) from longitudinal
(a), transverse cross sections (b, c), backscattered electron image (d) and X-ray pattern
for Zn-Li (e).
Fig.4.2 illustrates the optical microstructure, back-scattering electron imaging and XRD
result for the extruded Zn-Li wires. The longitudinal sections of the Zn-Li alloy after
drawing attained a preferential orientation at an angle of 27° with the extrusion direction.
As both LiZn4 and Zn possess hcp structure, so this 27° orientation may come from the
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formation of non-basal <c+a> slip system based on a junction between glissile <a> and
sessile c dislocations from the prism plane into a pyramidal plane, which is energetically
favorable for all hcp metals [40]. The transverse sections exhibited two main phases. The
bright phase is the Zn rich matrix and the dark phase corresponds to Li rich precipitates,
formed in the eutectic reaction. This is consistent with the BEI images in Fig.4.2(d). The
darkest precipitate phase (Li-rich phase) possessed the lowest average atomic number. The
area fraction and average particle size determined from the ImageJ software was 10±3 %
and 3.0 ± 0.5 m, respectively. This is a slightly larger value than the phase fraction of 6 %
calculated from the Zn-Li phase diagram at 200oC.
The XRD result in Fig.4.2(e) indicates that the two phases from the micrographs are the
zinc phase (43.24o and 39.02o) and the minor phase is LiZn4 (41.20o and 42.96o). For the
intermetallic LiZn4 phase (P63/mmc (No. 194), a=2.7702(8), c=4.3785(9)) [41], the
highest relative intensities of peaks came from the crystallographic plane sets of {002}.
According to Pearson’s Crystal powder pattern for LiZn4 (No. 1321631), the strongest peak
should be (101). This inconsistency could be due to the preferred orientation along (002)
exerted from the extruding process.
Table 4.2 summarizes the mechanical properties of Zn-Li wires compared with the 4N Zn
wire
Table 4.2. Mechanical properties of 4N Zn and Zn-Li wires
Yield strength

Tensile

Ductility

Ductility

Hardness

(MPa)

strength (MPa)

%elongation

%area reduction

(Vickers)

4N Zn

86 ± 14

116 ± 13

50 ± 5

97 ± 2

42 ± 3

Zn-Li

238 ± 60

274 ± 61

17 ± 7

74 ± 5

97 ± 2

Sample
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It should be noted that Zn-Li exhibited higher yield strength, tensile strength, hardness
and lower ductility than 4N Zn.
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Fig.4.3. Set-up for the tensile test (a), representative tensile stress-strain curve of 4N Zn
and Zn-Li (b) and fracture images of Zn-Li (c,d).

The representative tensile stress curve (Fig.4.3b) shows that the zinc alloy endured a
significant plastic deformation and necking before fracture occurred. The curve indicates
an ultimate tensile stress of 220 MPa and an elongation to failure of 24%. The average
strength values from the five Zn-Li wires increased by over 100% relative to 4N Zn and
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the ductility in percent of elongation was also retained at 17%, reaching the minimum
mechanical requirement for a stent [30]. The increase in strength could be due to the large
volume fractions of the LiZn4 phase for the alloy wires. SEM examination of the fracture
surface (Fig. 4.3c, d) revealed a clear necking shrinkage and dimpled surface, indicating a
moderately ductile behavior for the Zn alloy. The spherical “dimples” corresponding to
microvoids are believed to initiate the crack formation.
4.3.2 In vivo corrosion analysis
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Fig. 4.4. (a) Backscattered electron images and elemental maps (EDS) of Zn-Li wire
sections after residing in the rat arterial for 2 to 12 months; (b) FTIR spectrum of Zn-Li
wire for 13.5-month residence.
From the backscattered electron images (BEI), both the remaining metallic sections (shown
as the lighter phase) and the mixture of corrosion products, the epoxy and tissue (shown as
the darker phase) were detected. Dark areas inside the boundaries of explant cross sections
indicated a lower atomic number corrosion product made of zinc oxide, as will be
demonstrated later by x-ray maps. BEI images recorded after different periods of the alloy
wire explants (Fig.4.4a) indicated the loss of the circular wire integrity after 2 months of
in vivo degradation. It progressed further until 12 months.
Elemental maps of the same series of cross sections revealed the presence of the following
major elements: Zn, Ca, P, O, C and Cl (Fig.4.4a). At 2 months, a Ca and P-containing
exterior layer was detected adjacent to the inner layer containing Zn, C and O. A variation
in distribution of the corrosion products containing those elements is apparent from
elemental maps in Fig.4.4a. The outermost layer consists mainly of Ca and P, and the thin
layer adjacent to the metallic leftover is enriched with Cl, O and Zn, followed by a tiny
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content of C in particular regions. The distributions of Ca and P are almost identical,
indicating the presence of a more uniform layer of CaP at 2 months. This is in a disparity
to what was reported for the Mg wire [42], where Ca was incorporated in a more outer
layer than P. At 4 months, apart from the more evident loss of the metallic area, wire cross
sections are surrounded by ceramic layer composed of Ca and P elements, which thickness
appears to be more uniform around perimeter. The higher content of C at 4 months is
believed to be related to the penetration of epoxy into the oxide corrosion product, and not
result of the corrosion. This conclusion is in agreement with the contrast for the BEI image.
As shown in Fig.4.4, the distribution of Cl is similar to Zn. The high intensity Cl spot is
aligned with O, indicating the possible corrosion product of Zn-O-Cl. At 6.5 months, both
the CaP layer and the Zn-O layer thickened and the C signals started to appear in some
inner regions adjacent to O and Zn. This suggests the onset of the formation of Zn-O-C at
6.5 months. At 9 months, the coverage and distribution of all elements of interest around
metallic implant suggest increased amount of corrosion products, especially Zn-O-C.
Approximately 1/5 of the inner Zn area was lost at 12 months. The corrosion layer of ZnO segregated in the locations where most corrosion occurred. The layers of CaP and ZnO-C did not increase significantly as compared to the previous stage. The nearly identical
distribution of the Cl and Zn elements and the overlap between O and Cl in the enlarged
island area provide evidence for formation of Zn-O-Cl product(s) at 12 months.
FT-TR (infrared spectroscopy) was used to substantiate the surface products present on
explanted Zn alloy wires. In the FT-IR spectrum (Fig.4.4b), a narrow and high intensity
PO43- band is observed at 1050-1180 cm-1, which is related to the asymmetric stretching of
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the ν3 group [42,43]. The absorption band in the range of 920-1000 cm-1 is characteristic
of the symmetrical stretching of the ν1 group [44]. The CO32- bands from the ν3 apatitic
substitution were detected at 1390-1500 and 1540-1620 cm-1 [45,46].
Based on the signature of Zn, O, Ca, P, C from elemental map and the presence of PO 43and CO32- from FT-IR, it is assumed that the compact degradation product of Zn-Li
consisted of an inner Zn-O layer, followed by Zn-Cl-O, zinc carbonate (ZnCO3) and a
calcium phosphate (CaP) layer. Another possible corrosion product, Zn3(PO4)2·2H2O,
which is a more thermodynamically stable mineral at physiological pH [47] were absent
based on the lack of spatial overlapping between the elements Zn and P. This may either
indicate that the formation of Zn3(PO4)2·2H2O in this system needs longer time or that the
local pH had increased to above the physiological state due to the corrosion reaction:
Zn+O2+H2O = Zn2++4OH-.
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Fig. 4.5.(a) Typical ImageJ screenshot used for cross sectional analysis. The original local
cross-sectional area (yellow) is approximated by an ellipse. The red area selected by
thresholding is to represent the remaining Zn-Li alloy. (b) Penetration rates calculated from
reduction of cross sectional areas. (c) Cross sectional area reduction of alloy wires after
explanation.

Cross-sectional analysis showed an incremental increase of the degradation rate for Zn-Li
alloy during the implantation from 2 to 12 months. A moderate low degradation rate of
0.08 to 0.016 mm/yr was observed at 2 to 4 months. The earlier degradation for the alloy
wire was a little slower than that of 4N Zn and the benchmark for the ideal degradation
(0.02 mm/y) of medical implants [28]. However, the degradation of Zn-Li alloy accelerated
to 0.019 mm/yr at 9 months and 0.046 mm/yr at 12 months, which is twice as high as that
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of the 4N Zn sample (Fig.4.5b). This acceleration in later stage is preferred since the stent
would dissolve quickly in the body after the supporting function has ceased. Fig.4.5c
demonstrates the percent of cross sectional area reduction for 4N Zn and the Zn-Li alloy
over implantation time. The dashed line corresponds to the targeted cross area reduction of
20 μm/yr reported earlier [28]. The corroded area for Zn-Li was a little less than for 4N
Zn before 9 months and increased thereafter, which is consistent with the penetration rate
results shown in Fig.4.5b. Both 4N Zn and Zn-Li followed almost the same trend with the
targeted value and retained about 70% of the original area after 12 months in vivo. The
identical loss of area for 4N Zn and Zn-Li over 12 months indicates the very similar average
corrosion rate for the two materials. Surprisingly, the Zn-Li curve displayed a near-liner
relationship (R2 = 0.99) between the percent of area reduction and time, and the slope of
the curve (k = 2.63) was much closer to the target value (k = 2.67). This suggests a near
ideal uniform gradual acceleration of biodegradation for this alloy.
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4.3.3 In vivo biocompatibility analysis

Fig. 4.6. Arterial explants stained with H&E at 11 months. Low magnification images show
two subsequent areas selected for high magnification. “L” is the luminal opening of the
artery. Scale bars are 500 µm and 100 µm for 100x and 600x, respectively.
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Fig.4.6 also shows two areas of interest at higher magnification for the 11 month luminal
explants. Panels C and D demonstrate regions of chronic inflammation within the red circle
that correspond to the green asterisks on panels A and B.
In panel E, the blue asterisk identifies a media layer largely devoid of smooth muscle cells,
while panel F identifies a neo-intima largely populated with cells. These areas
corresponded to the red asterisks on panels A and B. It should be noted that the media layer
for the Zn-Li specimen appears largely deteriorated closer to the implant. Wide open
arterial lumens and low neointimal growth around the implant is evident from the images
and indicates excellent biocompatibility for Zn-Li, although inflammation and neointima
thickness appear to be slightly higher for Zn-Li relative to 4N Zn.

4.4 Discussion
4.4.1 The role of Li in the corrosion rate of Zn
It is known that alloying a second element into a metallic structure may not only change
the mechanical properties but also modify the corrosion behavior. In the Zn-Li alloys,
based on the optical micrographs and XRD results, it is assumed that element Li existed
partly in solid solution but also precipitated in the form of LiZn4 as part of a eutectic
structure.
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Fig. 4.7. Illustration of the galvanic effect between the Zn matrix and secondary phase in
physiological environment.

As shown schematically in Fig.4.7, there are two sources of galvanic corrosion in this
system: one is between the Zn-matrix and LiZn4 and the other is between the eutectic-Zn
and LiZn4. Due to the potential difference of the two, the precipitated secondary phase
LiZn4, which is nobler than Zn, can accelerate the corrosion of the matrix due to microgalvanic corrosion. However, the comparison of the penetration rates in Fig.4.5(b) showed
that the Zn-Li alloy corrodes slower than 4N Zn in the early stage. This can be explained
as follows: the area fraction of the LiZn4 phases as determined using the ImageJ software
is up to 10 ± 3%. During the corrosion processes these large amounts of precipitates could
act as an anodic barrier and an enrichment of the corrosion product (which consists of inner
Zn-O layer, Zn-Cl-O, ZnCO3 and CaP layer) to inhibit the overall corrosion rate of the
alloy. Therefore, the formation of the LiZn4 phase in this alloy contributes to a slower
corrosion of the Zn-Li alloy. The decrease of the susceptibility to atmospheric corrosion
resulting from alloying with Li was also detected in Mg-12 at.% Li [48]. Moreover, the
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molar ratio of LiZn4 to the adjacent eutectic-Zn for Zn-Li was 40% (calculated from the
Zn-Li phase diagram) and this may also influence the galvanic cells. Apart from the high
volume fraction effect, the aggregates of the corrosion layers from the uncorroded
intermetallic LiZn4 phase, together with other corrosion coatings consisting of zinc oxide,
perchlorate, carbonate and calcium phosphate layers also retarded the corrosions. However,
this decrease of the susceptibility to atmospheric corrosion from large volume fractions of
LiZn4 can be undermined with the progression of corrosion, as evidenced by the drastic
increase of the corrosion rate for the alloy wire after 9 months. This can be due to the
dissolution of the passive film and the incorporation of dissolved oxygen, ions or other
proteins and cells. In this way, the structure of the passive film will loosen and the previous
initiated pits may spread, which promotes a rapid attack of the bulk metal [49].
4.4.2 Corrosion mechanism
The production of the corrosion products in this system were estimated based on the
Pourbaix diagram of Zn-Li-H2O at 37oC (calculated using FactSage 7.0 software).
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Fig. 4.8. Zn-Li-H2O and Zn-Li-H2O-X Pourbaix diagrams for physiological
concentrations of X = {C, Cl, P } at 37 °C. Physiological pH of 7.4 is shown by the
dotted lines and physiological potential for tissue fluid is marked by the circles.

All of the thermodynamic equilibrium equations of Zn and Li with the physiological ions
present in H2O are shown in Fig.4.8. Zn-Li-H2O and Zn-Li-X-H2O diagrams are shown for
X = {C, P, Cl} and [Zn2+, Li+]={10-6}. To mimic the in vivo corrosion environment,
concentrations for Cl-, HPO42- and HCO3-(CO2(aq)) in this diagram were set to be identical
to the values in human blood plasma (0.1 mol/L for Cl-, 0.001 mol/L for HPO42-, and 0.027
mol/L for CO2(aq)) [50]. In the Zn-Li-H2O system, at low potentials of E < -1.4 V, both
Zn and Li are in the immunity region and thus stable in their metallic form. As Li possesses
higher activity than Zn, with potential increases, Li would be oxidized first. If surface
potential E is over -0.8 V, and at pH < 8.3, both Zn and Li would go into solution. The
Pourbaix diagram also shows that both the Zn2+ and Li+ are stable at low pH; the oxide,
ZnO, at intermediate pH; and the ZnO and LiOH at very high pH.
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The Pourbaix diagram is assumed to represent the thermodynamic equilibrium conditions.
On a contrary, in a real corrosion situation, the local pH values in the cathodic and anodic
areas are always higher and smaller, respectively, than at equilibrium. Therefore, the red
circles marked on the Pourbaix diagrams in Fig.4.8 which stand for physiological
conditions with tissue fluid (pH ≈ 7.4 and E ≈ 0.78 V) [51]. At pH ≈ 7.4, the Zn-Li-C-H2O
system reaches the equilibrium with ZnCO3 and ZnO as the corrosion product. In the
diagram of Zn-Li-P-H2O, it is believed that Zn3P2 only exists if the potential is in the range
of -0.7 V < E < -0.6V. At physiological potential, Zn3P2 dissolves and ZnO becomes the
only solid product. No Zn3(PO4)2·2H2O was detected under all conditions. From the
elemental mapping in Fig.4.4a, there was still a signal for a Zn-Cl-O mineral. However, in
the Zn-Li-Cl-H2O system, no solid Zn-Cl-O products were suggested around the potential
of the tissue fluid. It is possible that the as-formed chloride product was not stable at pH =
7.4. Zn5(OH)8Cl2·H2O, which can be formed due to the reaction of ZnCl2 with ZnO only
exists at a pH of 6.9. Furthermore, after implantation, apart from the contact with Cl-,
HCO3-, HPO42-, the Zn-Li alloy implants were also exposed to an environment rich in blood,
protein, cations (Na+, K+, Ca2+, Mg2+, etc.), organic substances of low-molecular-weight
species, polymeric components of high molecular-weight, as well as dissolved oxygen [52].
This physiological environment makes the corrosive medium extremely complex, which
can alter the properties of corrosion products and corrosion rates [51].
Based on the Pourbaix diagram, the following degradation sequence of the Zn-Li alloy in
a physiological environment is assumed: when Zn-Li is exposed to the aqueous solutions,
it shows some hydrogen gas evolution (Eq. 2), which is balanced by dissolution of Zn (Eq.
3). As dissolution progresses, the pH increases with the formation of OH- from the cathodic
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reaction, which promotes the production of ZnO according to the Pourbaix diagram. Along
with the deposition of a passive ZnO layer (Eq. 4), the existence of HCO3- (Eq. 5), Cl-(Eq.
6) and HPO42- (biomineralization from the introduction of calcium) in the body fluid also
favors thermodynamically the formation of new phases. The passive film would thus be
reconstructed into layers of zinc oxide, zinc chloride hydroxide, zinc carbonate and calcium
phosphate layer, as illustrated in schematic phase map in Fig. 4.9.
2H2O + 2e- = H2 + 2OH- (cathodic reaction)

Eq. 4.2

Zn(s) = Zn2+(aq) + 2e- (anodic reaction)

Eq. 4.3

Zn2+ + 2OH- = Zn(OH)2 = ZnO + H2O (product formation)

Eq. 4.4

H2O + CO2 = H2CO3 = HCO3- + H+
Zn2+ + 2HCO3- = ZnCO3 + H2 (product formation)Equation

Eq.4.5

Zn2+ + 2Cl- + 4ZnO + 5H2O = Zn5(OH)8Cl2·H2O (product formation)

Eq. 4.6

Fig. 4.9. Schematic phase map for 9-month residence.
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Based on histological observations, inflammation for the Li bearing metal consistently
appeared to be higher than for the 4N Zn wire. This increased inflammation did not
detrimentally affect the ability of the artery to propagate blood flow.

The greater

inflammatory response exhibited by Zn-Li over the 12 month evaluation period can be
explained by the increased variety of chemical species displayed to immune cells during
the course of the corrosion process, such as the LiZn4 intermetallic.

4.5 Conclusions
A new Zn-Li alloy has been cast, extruded and analyzed for biomedical-focused
applications. XRD results indicated the formation of LiZn4 through the emergence of
diffraction peaks corresponding to (002) and (101) for this phase. Mechanical testing
showed that alloying of Zn with 0.1 wt.% of Li increased the tensile strength from 116 ±
13 MPa (pure Zn) to 274 ± 61 MPa while the ductility was still being held at 17 ± 7%.
The elemental mapping and FT-IR analysis jointly confirmed that the corrosion products
are calcium phosphate, zinc oxide, zinc chloride hydroxide and zinc carbonate. The
quantitative corrosion analysis showed a moderate low degradation rate of 0.019 mm/yr at
6.5 months that increased to 0.046 mm/yr at 12 months. This later stage acceleration is
beneficial in that the stent would dissolve quickly in the body after the scaffolding function
ceased around 6 months. The corroded volume for Zn-Li was only slightly smaller than
that of 4N Zn at 6 months but both of them retained about 70% of their original dimensions
after 12 months in vivo. The nearly identical oxidation progression for 4N Zn and Zn-Li
indicates a very similar corrosion rate for the two materials. Moreover, the cross sectional
area reduction curve for Zn-Li displayed a near-liner relationship between the percent of
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area reduction and time. This suggests a near ideal uniform gradual acceleration of
biodegradation for this alloy. Biocompatibility results for the Zn-Li alloy at 11 months in
vivo indicated a moderate inflammation with a non-obstructive neointima.
All the preliminary results obtained from implantation in rat abdominal arteries
demonstrated that this new Zn-Li alloy is another promising bio-degradable coronary stent
material based on its improved mechanical properties and the outstanding corrosion
behavior as compared to pure Zn.
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Chapter 5 Summary

In this dissertation, a new class of Zn-xLi alloys (with x=2, 4, 6 at.%) was prepared by
induction melting in an argon atmosphere and processed through hot rolling for
biomedical-focused applications. XRD results indicate the formation of LiZn4 through the
emergence of diffraction peaks corresponding to (001) and (004) for this phase when
deformed by hot rolling, which increased hardness significantly in all cases. Mechanical
testing showed that alloying Zn with Li increases the tensile strength to 360 MPa with a
nominal addition of 2 at.% and 560 MPa with 6 at.% Li following hot rolling. Addition of
Li above the eutectic composition caused a severe decrease in elongation to failure making
the 6% Li alloy unsuitable for cardiovascular stent application.
In vitro corrosion behavior was evaluated by immersion tests in simulated body fluid. The
in vitro study with the newly formulated Zn-2Li and Zn-4Li alloys also demonstrates that
the corrosion rates and products in modified SBF solution closely resemble that of pure Zn
observed in vivo, in plasma, and in whole blood from previous studies. The Zn-4Li alloy
exhibited higher resistance to corrosion compared to Zn-2Li suggesting a positive effect of
Li content on protective characteristics of the corrosion layer. The findings herein
encourage further exploration of Zn-Li systems for structural use in biomedical vascular
support applications with the ultimate goal of simplifying stent procedures thereby
reducing stent related complications.
For the in vivo corrosion studies, a new Zn-Li alloy wire has been cast, extruded and
analyzed for biomedical-focused applications. XRD results indicated the formation of
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LiZn4 through the emergence of diffraction peaks corresponding to (002) and (101) for this
phase. Mechanical testing showed that alloying of Zn with 0.1 wt.% of Li increased the
tensile strength from 116 ± 13 MPa (pure Zn) to 274 ± 61 MPa while the ductility was still
being held at 17 ± 7%.
The elemental mapping and FT-IR analysis jointly confirmed that the corrosion products
are calcium phosphate, zinc oxide, zinc chloride hydroxide and zinc carbonate. The
quantitative corrosion analysis showed a moderate low degradation rate of 0.019 mm/yr at
6.5 months that increased to 0.046 mm/yr at 12 months. This later stage acceleration is
beneficial in that the stent would dissolve quickly in the body after the scaffolding function
ceased around 6 months. The corroded volume for Zn-Li was only slightly smaller than
that of 4N Zn at 6 months but both of them retained about 70% of their original dimensions
after 12 months in vivo. The nearly identical oxidation progression for 4N Zn and Zn-Li
indicates a very similar corrosion rate for the two materials. Moreover, the cross sectional
area reduction curve for Zn-Li displayed a near-liner relationship between the percent of
area reduction and time. This suggests a near ideal uniform gradual acceleration of
biodegradation for this alloy. Biocompatibility results for the Zn-Li alloy at 11 months in
vivo indicated a moderate inflammation with a non-obstructive neointima.
All the preliminary results obtained from implantation in rat abdominal arteries
demonstrated that this new Zn-Li alloy is another promising bio-degradable coronary stent
material based on its improved mechanical properties and the outstanding corrosion
behavior as compared to pure Zn.
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in ASM Phase Diagram Center. Permission to reuse material from the published work was
obtained with kind permission from ASM International. A copy of the granting permission
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Chapter 1 section 1.2.3 of this dissertation was originally published in “Biodegradable metals for cardiovascular stents: From clinical concerns to recent Zn‐alloys”,
2016 Advanced Healthcare Materials 5 (10), 1121-1140. Permission to reuse material from
the published work was obtained with kind permission from John Wiley and Sons. A copy
of the granting permission for reproduction is shown below.
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extrusion and drawing: Structural, mechanical characterization, and biodegradation in
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